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Programmed cell death (PCD) is crucial for cellular growth and development in 
multicellular organisms. Although distinct PCD features have been described for 
unicellular eukaryotes, homology searches have failed to reveal clear PCD-related 
orthologs among these organisms. Previous studies revealed that a surface-reactive 
monoclonal antibody MAb 1D5 could induce apoptosis-like PCD in the protozoan 
parasite Blastocystis. In the present study, through two-dimensional gel 
electrophoresis and mass spectrometry, the cellular target of MAb 1D5 was identified 
as a cell surface-localized legumain, an asparagine endopeptidase that is usually found 
in lysosomal/acidic compartments of other organisms. Recombinant Blastocystis 
legumain displayed biphasic pH optima in substrate assays, with peaks at pH 4 and 
7.4. Activity of Blastocystis legumain was greatly inhibited by legumain specific 
inhibitor Cbz-Ala-Ala-AAsn-EPCOOEt (APE-RR), and moderately inhibited by MAb 
1D5, cystatin and caspase-1 inhibitor. It was found that inhibition of legumain activity 
induced apoptosis-like PCD in Blastocystis, observed by increased externalization of 
phosphatidylserine (PS) residues and in situ DNA fragmentation. In contrast to plants, 
in which legumains have been shown to play a pro-death role, legumain appears to 
display a pro-survival role in Blastocystis. The data strongly suggest that legumain 
has a key role in the regulation of Blastocystis cell death.   
 
Previous studies demonstrated that besides apoptosis, MAb 1D5 could elicit a PCD 
response in Blastocystis independent of caspases-like activity, mitochondria, or both, 
suggesting the existence of an alternative cell death pathway. In this study, the use of 
autophagic marker monodansylcadaverine (MDC) and autophagic inhibitors 3-
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methyladenine and wortmannin showed the existence of autophagic cell death in 
MAb 1D5-treated Blastocystis. MAb 1D5-triggered autophagy was intensified in the 
presence of the caspase inhibitor zVAD.fmk and appeared to be dependent on 
mitochondrial outer membrane permeabilization (MOMP) since the MOMP inhibitor 
cyclosporine A could abolish MDC incorporation in MAb 1D5-treated cells, even in 
the presence of zVAD.fmk. This study is the first to report the occurrence of 
autophagy in Blastocystis through induction by a cytotoxic antibody. MDC staining of 
Blastocystis colony forms revealed that autophagy also occurs naturally in this 
organism. Amino acid starvation and rapamycin treatment are two common triggers 
of autophagy in mammalian cells and Blastocystis was found to rapidly up-regulate 
MDC-labeled autophagic vacuoles upon these inductions. Confocal microscopic and 
transmission electron microscopic studies also showed morphological changes 
suggestive of autophagy. The unusually large size of the autophagic compartments 
within the parasite central vacuole was found to be unique in Blastocystis. These 
results suggest that the core machinery for autophagy is conserved in Blastocystis and 
plays an important role in starvation response and cell death of the parasite. 
 
The last part of this study reports that staurosporine, a common apoptosis-inducer in 
mammalian cells, also induces cytoplasmic and nuclear features of apoptosis in 
Blastocystis, including cell shrinkage, PS externalization, maintenance of plasma 
membrane integrity, extensive cytoplasmic vacuolation, nuclear condensation and 
DNA fragmentation.  Staurosporine-induced PS exposure and DNA fragmentation 
was abolished by the MOMP inhibitor cyclosporin A and significantly inhibited by 
the broad cysteine protease inhibitor iodoacetamide. Interestingly, the apoptosis 
phenotype was insensitive to inhibitors of caspases and cathepsins B and L while 
 vii
calpain-specific inhibitors augmented staurosporine-induced apoptosis response. 
While the identities of the proteases responsible for staurosporine-induced apoptosis 
warrants further investigation, these findings demonstrate that PCD in Blastocystis is 






Chapter 1  
Introduction 
 
1.1 Biology of Blastocystis 
Blastocystis is a protozoan parasite found in the intestines of humans and many other 
animals. It is often the most common organisms isolated in parasitological surveys 
(Stenzel and Boreham, 1996; Tan, 2004, 2008; Zierdt, 1991a). The parasite was first 
described in the early 1900’s (Alexeieff, 1911; Brumpt, 1912) and has since then 
baffled researchers about its life cycle, pathogenesis, biochemistry, cellular and 
molecular biology. This organism has evoked considerable research interests due to 
its potential to cause intestinal diseases (Zierdt, 1991b) and the last decade or so has 
seen significant advances in our understanding of Blastocystis biology (Tan, 2008). 
 
1.1.1 Taxonomy and classification 
The taxonomic position of Blastocystis spp. has been controversial until the recently 
unambiguous placement of this organism into the stramenopiles (Arisue et al., 2002; 
Hoevers and Snowden, 2005; Silberman et al., 1996). It was initially suggested to be 
an yeast or fungus (Alexeieff, 1911; Brumpt, 1912) and the cyst of a flagellate 
(Haughwout, 1918). Zierdt and colleagues found that Blastocystis had some protistan 
features morphologically and physiologically. They classified this organism as a 
protist in the phylum Protozoa, subphylum Sporozoa (Zierdt et al., 1967), reclassified 
later to subphylum Sarcodina (Zierdt et al., 1988). Molecular sequencing studies of 
small-subunit rRNA indicated that Blastocystis is not monophylectic with the yeasts, 
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fungi, sarcodines or sporozoans (Johnson et al., 1989). Another study by Silberman et 
al. reported the complete sequence of Blastocystis small-subunit rRNA gene and 
showed that it could be placed among the stramenopiles (Silberman et al., 1996). Yet 
two studies using the sequence of elongation factor-1α (EF-1α) suggested that 
Blastocystis diverged before the stramenopiles and was related to Entamoeba 
histolytica (Ho et al., 2000; Nakamura et al., 1996). However, both studies with EF-
1α were criticized by its low statistical significance and other factors, which made the 
phylogenetic position of Blastocystis inaccurate (Tan, 2008; Tan et al., 2002). A 
recent study used multiple molecular sequence data (including small-subunit rRNA, 
cytosolic-type 70 kD heat shock protein, translation elongation factor 2 and the non-
catalytic ‘B’ subunit of vacuolar ATPase) and clearly showed that Blastocystis is a 
stramenopile (Arisue et al., 2002).  
 
The Stramenopiles, also called Chromista and Heterokonta, are a diverse group of 
unicellular and multicellular protists comprising of heterotrophic and photosynthetic 
representatives, and are characterized by their flagella and hair-like projections 
extending laterally from the flagellum (mastigonemes). Blastocystis does not have 
flagella and is non-motile. Therefore, it is placed in a new class called Blastocystea, 
subphylum Opalinata, infrakingdom Heteokonta, subkingdom Chromobiota, 
kingdom Chromista (Tan, 2008). The closest species to Blastocystis is Proteromonas 
lacertae (Arisue et al., 2002; Silberman et al., 1996). 
 
The designation of Blastocystis subsets has also been bewildering because different 
studies used different methods to subtype and classify Blastocystis sp., which made 
corroboration, comparison or criticism of publications very difficult. Due to the 
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urgency of a standard terminology in this research field, a group of investigators from 
different laboratories came up with a consensus on the terminology of Blastocystis 
subtypes (Stensvold et al., 2007a). In the past, Blastocystis isolates from humans was 
designated Blastocystis hominis, whereas Blastocystis isolates from other animals was 
usually named Blastocystis sp., or specific names according to the host origin, such as 
Blastocystis ratti. However, this old practice of assigning Blastocystis species 
according to host origin is misleading because of the extensive genetic diversity of 
this organism even among isolates from one host. Therefore, the current consensus 
terminology recommends that all mammalian and avian isolates are designated 
Blastocystis sp. and assigned to a subtype from 1 to 9 by a simplified small subunit-
rDNA typing method (Stensvold et al., 2007a; Stensvold et al., 2007b). Table 1.1 
shows the new designations of some commonly studied Blastocystis isolates. Humans 
can be host to Blastocystis spp. originated from various mammals (subtype 1), 
primates and pigs (subtype 2), rodents (subtype 4), cattle and pigs (subtype 5), and 
birds (subtype 6 and 7) (Tan, 2008). 
 
Table 1.1 Old and new classification of commonly studied Blastocystis isolates based 
on a consensus terminology* (adapted from Tan, 2008) 
 
Species Isolate(s) Culture type Host New designation 
B. hominis Nand II Axenic Human Blastocystis sp. subtype 1 
B. hominis Si Axenic Human Blastocystis sp. subtype 1 
B. hominis B, C, E, G, H Axenic Human Blastocystis sp. subtype 7 
B. ratti S1, WR1, WR2 Axenic Rat Blastocystis sp. subtype 4 
Blastocystis sp. NIH:1295:1 Xenic Guinea pig Blastocystis sp. subtype 4 
*proposed by Stensvold et al., 2007a 
 4
1.1.2 Morphology 
Blastocystis is a polymorphic organism and four major forms (vacuolar, granular, 
amoeboid and cyst) are commonly observed in fecal and laboratory culture samples 
(Stenzel and Boreham, 1996; Tan et al., 2002; Zierdt et al., 1967).  
 
The vacuolar form, also referred to as the central vacuole form, is the predominant 
cell form seen in stool samples and axenized in vitro cultures and considered to be the 
typical Blastocystis cell form (Figure 1.1 A). It is spherical and varies greatly in size, 
diameter ranging from 2 to 200 µm with average diameters of 4 to 15 µm (Stenzel and 
Boreham, 1996). The characteristic large vacuole occupies up to 90% of the cell 
volume, surrounded by a thin rim of cytoplasm containing organelles such as the 
nucleus, Golgi apparatus, endoplasmic reticulum and mitochondrion-like organelles 
(Tan et al., 2002).  
 
The granular form (Figure 1.1 B) is morphologically similar to the vacuolar form, 
except that there are granules in the cytoplasm or more commonly in the central 
vacuole. The granular form is slightly larger in size, with average diameters of 3 to 
80 µm (Dunn et al., 1989a; Zierdt and Williams, 1974). They are usually seen in non-
axenized and older cultures (Tan, 2004). 
 
The amoeboid form (Figure 1.1 C) has been rarely identified with conflicting reports 
on its morphology (Dunn et al., 1989a; McClure et al., 1980; Tan et al., 1996b). 
Generally it is irregular in shape and often has extended pseudopodia, but appears 
non-motile despite the observation of pseudopods. They are usually observed in old or 
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antibiotic-treated cultures (Zierdt, 1973), and in Blastocystis colonies grown in soft 
agar (Tan et al., 1996b). 
 
The cyst form (Figure 1.1 D) was discovered most recently (Mehlhorn, 1988; Stenzel 
and Boreham, 1991). It is smaller in size (2 to 5 µm) than the other three forms and is 
surrounded by a thick multi-layered cyst wall. The cyst form has been reported to 
withstand environmental stress. Unlike the vacuolar and granular form, cysts are able 
to resist lysis by distilled water, and are able to survive at room temperature for up to 
19 days (Zaman, 1998; Zaman et al., 1995). The cyst form has been shown to be the 
infective stage by several experimental infectivity studies with mice, rats and birds 




Figure 1.1 Morphological forms of Blastocystis. Light micrographs of (A) vacuolar 
forms; (B) granular forms; (C) amoeboid pseudopod-like cytoplasmic extensions (*); 
and (D) cyst forms. CV, central vacuole; Nu, nucleus. (Tan, 2007) 
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1.1.3 Life cycle and mode of transmission 
A number of conflicting life cycles have been proposed for Blastocystis (Boreham and 
Stenzel, 1993; Singh et al., 1995; Zierdt, 1973) and controversies about these modes 
of division are due to the lack of experimental proof. Different modes of reproduction 
such as schizogony (Singh et al., 1995), plasmotomy (budding) (Tan and Suresh, 
2007), endodyogeny (Zhang et al., 2007) and sac-like pouches (Suresh et al., 1997) 
have been postulated based on observations in different studies. However, the only 
accepted mode of reproduction should be binary fission until proven otherwise (Tan, 
2008). 
 
A revised life cycle incorporating information on animal infection studies and the 
recent phylogenetic studies was proposed (Tan, 2004, 2008). The proposed life cycle 
(Figure 1.2) suggests that cyst form is the infective stage and the infection by this 
parasite occurs in humans and animals by fecal-oral route. The cysts develop into 
vacuolar forms in the large intestines. In the human intestine, vacuolar forms divide 
by binary fission and may develop into amoeboid or granular forms. Encystations of 
vacuolar forms may occur in host intestines and intermediate cysts may have a thick 
fibrillar layer which is lost during the passage in the external environment. Humans 
are potentially infected by seven or more subtypes (subtype 1 to 7) of Blastocystis and 
certain animals are reservoirs for transmission to humans. Subtype 1 is cross-infective 
among mammals and birds. Subtypes 2, 3, 4, and 5 are primate/pig, human, rodent 





Figure 1.2 Life cycle of Blastocystis proposed by Tan, 2008. The proposed scheme 
suggests that humans are potentially infected by seven or more subtypes (subtype 1 to 
7 as shown by the numbers 1 to 7) of Blastocystis and that certain animals are 
reservoirs for transmission to humans. Hypothetical pathways are represented by 
dotted arrows. 
 
1.1.4 Epidemiology and prevalence 
Blastocystis is often the most frequently isolated parasite found in the fecal samples of 
both healthy individuals and patients suffering from intestinal disorders (Cirioni et al., 
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1999; Pegelow et al., 1997; Stenzel and Boreham, 1996; Wang, 2004). Prevalence of 
Blastocystis infection is higher in developing countries at a carriage rate up to 60% 
(Pegelow et al., 1997) and this has been linked to poor hygiene and deficient in 
sanitation facilities. Increased risk of infection may also be associated with 
occupations that involve exposure to animals (Rajah Salim et al., 1999). 
 
1.1.5 Pathogenesis 
The pathogenicity of Blastocystis is currently a matter of debate as there have been 
numerous studies either implicate or exonerate the parasite as a cause of diseases 
(Clark, 1997; Stenzel and Boreham, 1996; Tan et al., 2002).  
 
A prospective controlled study suggested that there was no obvious difference in the 
prevalence of Blastocystis in individuals with and without diarrhea and hence 
Blastocystis was not an important diarrhea-causing agent (Shlim et al., 1995). Another 
case-controlled study (Leder et al., 2005) concluded that there was no correlation 
between clinical symptoms and Blastocystis infection in immunocompetent 
individuals. However, these studies can be questioned because clinical outcome is 
multifactorial and influenced by host and parasite factors (Tan, 2008). For example, 
infections with other established enteric protozoan pathogens such as Giardia and 
Entameoba do not always lead to disease. In addition, many of these studies are based 
on the assumptions that Blastocystis is biologically homogenous, but in fact this 
organism may have inter-subtype and intra-subtype variation in pathogenesis.  
 
In two reports on placebo-controlled treatment of symptomatic but immunocompetent 
patients with Blastocystis as the solely identified pathogen (Nigro et al., 2003; 
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Rossignol et al., 2005), therapeutic improvement was found concomitant with the 
clearance of Blastocystis. However, critics of these studies may include the existence 
of some unidentified pathogen.  
 
There are also some in vitro studies sought to investigate the effects of Blastocystis on 
mammalian cell cultures. Walderich et al. showed that Blastocystis could cause 
cytopathic effects in Chinese hamster ovary and HT 29 cells (Walderich et al., 1998). 
Puthia et al. showed that cysteine proteases of Blastocystis were able to cause 
significant degradation of human secretory immunoglobulin A, compromise barrier 
function of intestinal epithelial cells, cause host cell apoptosis, and induce 
proinflammatory cytokines (Puthia et al., 2008; Puthia et al., 2006; Puthia et al., 
2005). These studies support a pathogenic role for Blastocystis. 
 
It is suggested that because there are no reports unequivocally proving Blastocystis is 
nonpathogenic and there are accumulating epidemiological, in vitro and animal 
studies strongly suggesting the pathogenic potential of the parasite, it would be 
prudent to consider Blastocystis as an emerging protozoan pathogen (Tan, 2008). In 
the meanwhile, a good animal model should be developed to test Koch’s postulates 
and to fill the gap of our understanding in the pathogenesis of Blastocystis. 
 
1.2 Types of cell death 
Cell death is a fundamental biological process. Programmed cell death (PCD) is 
generally opposed to 'accidental cell death', that is necrosis induced by pathological 
stimuli (Kroemer et al., 2005). PCD is a highly regulated cellular suicide process in 
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eukaryotes (Hatsugai et al., 2006). PCD is involved in a variety of biological events 
such as morphogenesis, aging, maintenance of tissue homeostasis and elimination of 
infected or malignant cells. Thus PCD plays a crucial role in the development and 
homeostasis of multicellular organisms and deregulation of this process contributes to 
major pathologies, including cancer, autoimmune diseases, and neurodegenerative 
diseases (Lenardo et al., 1999; Okada and Mak, 2004; Yuan and Yankner, 2000). 
 
Cell death can occur through different mechanisms resulting in distinct morphologies. 
Three major morphologies of cell death have been described: apoptotic (or Type I), 
autophagic (or Type II) and necrotic (or Type III) cell death (Clarke, 1990; Kroemer 
et al., 2005; Schweichel and Merker, 1973). 
 
1.2.1 Type I cell death – apoptosis 
Apoptosis is the most common and well-defined form of PCD. The term ‘apoptosis’ 
(meaning ‘falling leaves’ in Greek) was coined more than 30 years ago to remark on 
the distinctive morphological features observed in this type of cell death (Kerr et al., 
1972). A cell undergoing apoptosis shows a characteristic morphology including 
rounding-up of the cell, retraction of pseudopods, cellular volume reduction 
(pyknosis), chromatin condensation, nucleus fragmentation (karyorhexis), little or no 
ultrastructural modification of cytoplasmic organelles, plasma membrane blebbing, 
and maintenance of plasma membrane impermeability until late stages of the process 
(Ameisen, 2002; Kroemer et al., 2005). Blebbing of the plasma membrane leads to 
the formation of apoptotic bodies, which are engulfed by phagocytes in the absence of 
any inflammatory response(Henson et al., 2001; Savill et al., 2002). 
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Apoptosis in mammalian cells is mediated primarily, although not exclusively, by a 
family of cysteine proteases called caspases (Nicholson, 1999; Salvesen and Dixit, 
1999). Caspases cleave their substrates specifically after the aspartate residues. 
Caspases can be divided into inflammatory caspases and pro-apoptotic caspases, 
which can be further grouped into initiator and effector caspases (Leist and Jaattela, 
2001). They are normally expressed in healthy cells as inactive precursor enzymes. 
When initiator caspases such as caspases-8 or caspases-9 oligomerize and undergo 
autoproteolysis, they become active and cleave the precursor form of effector 
caspases, such as caspases-3, caspases-6 and caspases-7. Activated effector caspases 
in turn cleave a specific set of cellular substrates, leading to the biochemical and 
morphological changes associated with apoptosis.  
 
Three major pathways of apoptosis-associated caspase activation (Figure 1.3) have 
been firmly established – the extrinsic, intrinsic and granzyme B pathway  (Taylor et 
al., 2008). The extrinsic pathway is activated by the binding of extracellular death 
ligands such as FasL or tumor necrosis factor-α (TNF-α) to transmembrane death 
receptors on cell surface, inducing the formation of the death-induced signaling 
complex (DISC). DISC in turn recruits caspase-8 and promotes its autoprocessing and 
the cascade of procaspase activation that follows (Nagata, 1999; Peter and Krammer, 
1998; Wajant, 2002). In the intrinsic pathway, various extracellular and intracellular 
stresses activate one or more members of the BH3-only protein family. The activation 
of BH3-only protein above a threshold level overcomes the inhibitory effect of the 
anti-apoptotic B-cell lymphoma-2 (BCL-2) family members and promotes the pro-
apoptotic BCL-2 family members such as BAX and BAK to form pores in the 
mitochondria outer membrane. Upon mitochondrial outer membrane permeabilization 
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(MOMP), cytochrome c is released and seeds the assembly of apoptosome where 
caspase-9 becomes active and then propagates the caspase activation cascade 
(Kroemer et al., 2007). The granzyme B pathway takes place in cytotoxic lymphocyte 
killing where cytotoxic T lymphocytes (CTL) or natural killer (NK) cells release 
granules containing granzyme B and perforin to their target cells. Granzyme B enters 
target cells through pores formed by oligomerization of perforin, and directly 
activates effector caspases because they have the same specificity as that of caspases 
to cleave after aspartate residues (Lord et al., 2003; Martin et al., 1996). Granzyme B 
can initiate mitochondrial events by cleaving the BH3-only protein BID (BH3-
interacting domain death agnoist). Truncated BID (tBID) can promote mitochondrial 
cytochrome c release and apoptosome assembly (Barry et al., 2000). In some 
situations, BID also serves as a link between the extrinsic and intrinsic apoptotic 




Figure 1.3 Caspase activation pathways (Taylor et al., 2008) 
 
Because of the pivotal roles of caspases in the execution of apoptosis, it has been 
frequently thought that apoptosis equals caspase activation. However, this belief is 
challenged by the fact that apoptotic cell death can still occur even when the caspase 
cascade is blocked, primarily because there are caspase-independent mechanisms of 
cell death,  the main mediators being certain mitochondrial proteins or noncaspase 
proteases (Abraham and Shaham, 2004; Kroemer and Martin, 2005; Yuan et al., 
2003). 
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The induction of MOMP is a critical event in apoptosis and often defines the point of 
no return (Kroemer and Reed, 2000). Most pathways upstream of MOMP are 
independent of caspases. Upon induction of MOMP, mitochondria can release 
cytochrome c and lead to the classical caspase-dependent pathway. However, other 
caspase-independent effectors such as apoptosis-inducing factor (AIF), endonuclease 
G and HtrA2/Omi can also be released from mitochondrial intermembrane space and 
promote caspase-independent death, although the mechanisms are not fully 
understood (Lorenzo and Susin, 2004; van Gurp et al., 2003). AIF is a flavoprotein 
which has important function in bioenergetic and redox metabolism and is confined to 
the mitochondria in healthy cells. When MOMP has occurred, AIF translocates to the 
nucleus, where it interacts with DNA, triggering chromatin condensation and DNA 
degradation into large fragments of about 50 kb (Cande et al., 2002; Susin et al., 
1999). Endonuclease G is another protein which translocates from mitochondria to the 
nucleus upon MOMP, and it extensively cleaves nuclear DNA into nucleosomal 
fragments (Li et al., 2001; van Loo et al., 2001). HtrA2/Omi is a mitochondrial serine 
protease which can be released into cytosol and induce apoptosis in a caspase-
independent manner through its protease activity as well as in a caspase-dependent 
manner by binding to inhibitor of apoptosis proteins (IAPs) and subsequently 
activating caspases (Hegde et al., 2002; Suzuki et al., 2001). 
 
Caspase-independent death can also result from stimuli that cause lysosomal 
membrane permeabilization (LMP) and the consequent release of cathepsin proteases. 
Lysosomal proteases were considered to only take charge of nonspecific degradation 
of proteins within lysosomes and contribute to necrotic cell death upon massive 
lysosomal rupture, but recently it has become evident that upon moderate lysosomal 
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damage lysosomal proteases have an active and specific role in apoptotic cell death, 
sometimes without the apparent activation of caspases (Johnson, 2000; Stoka et al., 
2007). The cathepsins family consists of cysteine cathepsins (cathepsin B, C, F, H, K, 
L, O, S, V, X, W), the aspartate protease cathepsin D and the serine protease 
cathepsin G (Turk et al., 2000). Cathepsin B and D are most stable at physiologic, 
cytoplasmic pH and are found to be involved in apoptosis. In bile salt-induced 
apoptosis of rat hepatocytes, cathepsin D and B were found to be activated in a 
cascade-like fashion downstream of caspases and cathepsin B translocated to the 
nucleus as the effector protease (Roberts et al., 1999; Roberts et al., 1997). Cathepsin 
B was also shown to be a dominant execution protease downstream of caspases in 
several tumor cell lines (Foghsgaard et al., 2001). However, cathepsin B can also be a 
cell death mediator independent of caspases in WEHI-S fibrosarcoma and non-small 
cell lung cancer (NSCLC) cells (Broker et al., 2004; Foghsgaard et al., 2001). 
Cathepsins can induce cell death in a mitochondrion-dependent manner, by cleaving 
the Bcl-2 family protein Bid and leading to the mitochondrial release of pro-apoptotic 
factors (Heinrich et al., 2004; Stoka et al., 2001), or by activating Bax with the 
subsequent release of AIF from mitochondria (Bidere et al., 2003). 
 
The calcium-dependent cytosolic protease calpains have also been described as 
mediators of apoptosis (Wang, 2000). Calpains can participate in apoptosis signaling 
downstream or upstream of caspases. For example, caspases have been shown to 
cause the cleavage of the natural calpain inhibitor calpastatin and lead to the 
activation of calpain (Porn-Ares et al., 1998). Calpains can act downstream of 
caspases and contribute to the degradation phase of apoptosis of HL-60 cells (Wood 
and Newcomb, 1999). In other apoptosis models, calpain activation is upstream of 
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caspases (Waterhouse et al., 1998) and calpain activates caspase-12 (Nakagawa and 
Yuan, 2000). However, calpain is also capable to execute cell death in complete 
absence and independent of caspases in vitamin D-induced apoptosis of the breast 
cancer cell line MCF-7 (Mathiasen et al., 2002). 
 
1.2.2 Type II cell death – autophagic cell death 
Type II, or autophagic cell death is characterized by increased number of autophagic 
vacuoles in the cytoplasm, without chromatin condensation (Kroemer et al., 2005; 
Schweichel and Merker, 1973). The autophagic vacuoles are double-membraned and 
contain degenerating cytoplasmic organelles or cytosol (Levine and Klionsky, 2004b). 
Type II cell death is morphologically distinct from apoptosis. In classical apoptosis, 
cytoskeletal elements collapsed early but organelles are preserved until late apoptosis, 
whereas in autophagic cell death, organelles are degraded early and cytoskeletal 
elements are preserved until late stage (Bursch et al., 2000). Autophagic cell death 
proceeds without chromatin condensation or DNA fragmentation, which are 
characteristics of apoptosis (Levine and Yuan, 2005). In vivo, residues of cells 
undergoing type II cell death are phagocytosed by neighboring cells, just like those of 
apoptosis, and there is no tissue inflammatory response (Schweichel and Merker, 
1973). The term ‘autophagic cell death’ often misleads people to believe that cell 
death is occurring through autophagy, but in fact the term simply describes cell death 
with autophagy because there is no conclusive evidence of a causal relationship 
between autophagy and cell death (Tsujimoto and Shimizu, 2005). 
 
Autophagy is the major mechanism used by eukaryotic cells to degrade long-lived 
proteins and perhaps the only known pathway for degrading organelles (Levine and 
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Klionsky, 2004a). It is believed to be a conserved process in all eukaryotic cells. 
Autophagy is kept at low basal levels to serve homeostatic functions but is rapidly up-
regulated in response to growth-factor withdrawal, starvation, differentiation and 
developmental triggers (Kuma et al., 2004; Levine and Klionsky, 2004a; Shintani and 
Klionsky, 2004; Takeshige et al., 1992). Autophagy also plays a role in the 
destruction of intracellular pathogens (Gutierrez et al., 2004). 
 
At least three forms of autophagy (chaperone-mediated autophagy, microautophagy 
and macroautophagy) have been recognized, based on their mechanisms, 
physiological functions and cargo specificity (Kourtis and Tavernarakis, 2009). 
Macroautophagy has been most extensively studied and is generally simply referred 
as autophagy. During macroautophagy (hereafter referred to as autophagy), a double-
membrane structure called phagophore forms and expands to sequester a portion of 
cytoplasm in the form of an autophagosome. The autophagosome will fuse with a 
lytic compartment and the engulfed materials are degraded and the resulting 
macromolecules are recycled (Figure 1.4) (Klionsky and Emr, 2000; Levine and 








Our understanding of the molecular basis of autophagy has been significantly 
advanced by analyses of autophagy-defective mutants in yeasts (Klionsky et al., 2003; 
Tsukada and Ohsumi, 1993). There are 32 autophagy-related (ATG) genes identified 
in Saccharomyces cerevisiae and other fungi, and many yeast ATG genes have 
orthologs in mammalian cells (Kanki et al., 2009; Klionsky, 2007; Okamoto et al., 
2009). The ATG genes encode proteins required for the induction of autophagy, and 
the nucleation, expansion, maturation and recycling of autophagosomes (Xie and 
Klionsky, 2007). Upstream of Atg proteins, several protein kinases regulate 
autophagy, including at least the phosphatidylinositol 3-kinase (PI3K) and the target 
of rapamycin (TOR) kinase. TOR is the major inhibitory signal of autophagy during 
nutrient abundance because it negatively regulates autophagosome formation and 
expansion (Kamada et al., 2000). The class I PI3K/Akt signaling pathway is activated 
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by receptor tyrosine kinase and activates TOR to suppress autophagy in the presence 
of insulin-like and other growth factor (Lum et al., 2005a).  
 
As mentioned above, the exact role of autophagy in type II cell death is still unclear 
and has been an ongoing debate in the scientific community (Gozuacik and Kimchi, 
2004; Kroemer and Levine, 2008; Levine and Yuan, 2005). The presence of 
autophagic vacuoles in dying cells may result from two possibilities: autophagy is the 
death execution mechanism, or autophagy is an adaptive response to rescue cells 
under stress conditions. Theoretically, in order to determine that autophagy observed 
in a cell is truly a death mechanism, inhibition of autophagy by pharmacological 
inhibitors or RNA interference (RNAi) would prevent cell death. However, the 
inhibition of autophagy often shifts the appearance of cell death to another type such 
as apoptosis and necrosis, instead of effectively enhancing cell survival (Kosta et al., 
2004). In some cases, autophagic cell death is prevented while autophagy is still 
observed (Lee and Baehrecke, 2001). These may suggest that autophagy per se is 
neither sufficient nor required for autophagic cell death (Levine and Yuan, 2005).  
 
There are some studies which indicate that the autophagy pathway is capable of 
killing cells. Bax-/-, bak-/- murine embryonic fibroblasts (MEFs) fail to exhibit 
classical apoptosis upon exposure to cytotoxic agents, yet are capable of dying with a 
type II morphology. This death is blocked by RNAi against autophagy gene Atg5 and 
Atg6/Beclin 1 (Shimizu et al., 2004). In another study, RNAi directed against 
Atg6/Beclin 1 and Atg7 suppressed cell death in mouse L929 fibrosarcoma cells 
treated with the caspase inhibitor zVAD.fmk (Yu et al., 2004). In bax-/-, bak-/- MEFs, 
autophagy seems to be required for the induction of necrotic death in response to 
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endoplasmic reticulum (ER) stress (Ullman et al., 2008). However, the physiologic 
relevance of autophagy gene-dependent cell death in cells whose apoptotic machinery 
has been crippled is uncertain (Levine and Yuan, 2005). Recent studies of the 
Drosophila salivary gland development have shown that both apoptosis and 
autophagy are required for the degradation of these organs (Berry and Baehrecke, 
2007), giving the first strong evidence that even in the presence of apoptotic factors, 
autophagy is required for physiological autophagic cell death during development 
(Berry and Baehrecke, 2008). 
 
There are also studies supporting that autophagy in the dying cells is a pro-survival 
mechanism, and type II morphology may result from the failure of cells to adapt. For 
example, following growth factor withdrawal, bax-/-, bak-/- cells rapidly show 
reduced ATP levels and compromised bioenergetics and will die if autophagy is 
inhibited, but bax-/-, bak-/- cells with intact autophagic machinery can sustain 
viability for several weeks. Although these cells die eventually, at any point before 
cell death, the addition of growth factor reserves the catabolic responses and 
maintains cell viability (Lum et al., 2005a).  
 
The exact role of autophagy in cell death and survival is rather complicated and 
cellular context-dependent. It appears that autophagy probably functions initially as a 
cytoprotective response, but if cellular damage is too extensive or if apoptosis is 
compromised, excessive autophagy may be used to kill the cell. Autophagic cell death 
may be important for complete self-degradation when phagocytes are unavailable 
(Berry and Baehrecke, 2008). The resources generated by autophagic cell death of 
individual cells may promote survival of the organism (Galluzzi et al., 2008). 
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1.2.3 Type III cell death – necrosis 
Type III cell death, or necrosis, is usually defined negatively as a type of cell death 
without signs of apoptosis or autophagy (Kroemer et al., 2005). The morphological 
features of necrosis include early plasma membrane rupture, cytoplasmic swelling and 
vacuolation, dilation of cytoplasmic organelles such as mitochondria, ER and Golgi 
apparatus, as well as moderate chromatin condensation (Edinger and Thompson, 2004; 
Kroemer et al., 2005). Necrosis is usually a consequence of patho- or supra-
physiological condition, such as infection, inflammation, ischemia, mechanical force, 
heat or cold damage (Zong and Thompson, 2006). The traumatic cell destruction leads 
to release of intracellular components and triggers inflammatory immune responses 
(Edinger and Thompson, 2004). Although necrosis has been conceived as a passive 
and uncontrolled form of cell death, recent evidences suggest that necrosis can also be 
a regulated event and programmed necrosis may serve to maintain the integrity of 
tissue and organism (Festjens et al., 2006; Zong and Thompson, 2006). 
 
Table 1.2 summarizes the characteristics of the three different types of cell death 









Table 1.2 Characteristics of different types of cell death 
 Type I apoptotic Type II autophagic Type III necrotic 




Partial chromatin condensation 
Nucleus intact until late stages 
No DNA laddering 
Clumping 
Random degradation of DNA 
Cell membrane Blebbing 
 
Blebbing Swelling; rupture 
Cytoplasm Cytoplasmic condensation 
Fragmentation to apoptotic bodies  
 
Increased number of autophagic vesicles Increased vacuolation  





Caspases are active Caspase-independent 
Increased lysosomal activity 
 
Not well characterized 
Detection 
methods 
Electron microscopy  
TUNEL staining 
Annexin V staining 
Increase in sub G1 cell population 
Nuclear fragmentation detection 
Caspase activity assays 
Electron microscopy 
Test of increased long-lived protein 
degradation 
MDC staining 




Nuclear staining (usually negative) 
Detection of inflammation and damage 
in surrounding tissues 
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1.3 Programmed cell death (PCD) in protozoan parasites 
PCD has long been recognized as an essential process to eliminate the unwanted or 
damaged cells and thus to ensure normal growth and development in multicellular 
organisms. It was assumed that PCD arose with multicellular organisms (Vaux et al., 
1994). However, recently considerable experimental evidences have been 
accumulated towards the existence of PCD in unicellular eukaryotes. These include 
non-parasitic organisms, such as yeast (Madeo et al., 2002), the free living slime mold 
Dictyostelium discoideum (Arnoult et al., 2001; Cornillon et al., 1994), the free living 
ciliate Tetrahymena thermophila (Christensen et al., 1998; Kobayashi and Endoh, 
2005) and the dinoflagellate Peridinium gatunense (Vardi et al., 1999). In parasitic 
organisms, PCD has been described in the kinetoplastid trypanosomes (Ameisen et al., 
1995; Welburn et al., 1996) and Leishmania (Arnoult et al., 2002; Bera et al., 2003; 
Zangger et al., 2002), the apicomplexan parasite Plasmodium (Al-Olayan et al., 2002; 
Deponte and Becker, 2004), trichomonads (Mariante et al., 2006), Giardia lamblia 
(Chose et al., 2003) and Blastocystis (Tan and Nasirudeen, 2005). 
 
1.3.1 Occurrence of PCD in unicellular eukaryotes 
The baker’s yeast Saccharomyces cerevisiae is probably the best-known eukaryotic 
organism and its PCD machinery is also the best studied among unicellular organisms 
(Frohlich et al., 2007). The first observation that yeast can exhibit apoptotic markers 
was made on a strain carrying a mutation in the cell division cycle gene CDC48 
(Madeo et al., 1997). Mutations or heterologous expression of proapoptotic genes also 
induce PCD in yeast. Yeast can also undergo apoptosis in some physiological 
scenarios such as cellular aging, failed mating, or exposure to killer toxins (Buttner et 
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al., 2006). The yeast metacaspase YCA1 has been shown to have similar functions of 
caspase and mediate apoptosis in yeast (Madeo et al., 2002). Other crucial proteins of 
the basic molecular machinery executing cell death are also found to be conserved in 
yeast, such as AIF and HtrA2/Omi (Frohlich et al., 2007). Autophagy genes have 
been characterized in yeast (Klionsky, 2007) and autophagic cell death can be 
triggered (Abudugupur et al., 2002). Due to its ease of genetic manipulation and the 
simplicity of PCD pathway, yeast has been used as a model organism to study the 
mechanism of PCD and to identify new regulators of PCD from other organisms. 
 
Dictyostelium discoideum grows as a colony of cycling single cells, but upon 
starvation this slime mold forms multicellular aggregates made of a stalk of dead cells 
that support the viable spores (Ameisen, 2002). The ease to grow in vitro, availability 
of fully sequenced genome, and well established genetic tools make this protist a good 
model to study different modes of PCD (Tresse et al., 2007). Apoptotic and non-
apoptotic PCD features was observed in stalk cells in an in vitro system involving 
differentiation without morphogenesis (Cornillon et al., 1994), but no DNA 
fragmentation was detected in this study. However, in another study of similar 
settings, DNA degradation was detected and a homolog of human AIF of D. 
discoideum was shown to translocate from mitochondria to the nucleus during cell 
death, and was suggested to be involved in DNA degradation (Arnoult et al., 2001). A 
vacuolar, autophagic type of cell death was triggered by developmental stimulation of 
the D. discoideum HMX44A strain with no signs of apoptosis, whereas genetic 
inactivation of the Atg1 autophagy gene switched the mode of cell death to from 
autophagic cell death to necrotic cell death (Tresse et al., 2007). 
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Unicellular protozoan parasites cause a wide variety of human diseases. Current 
treatment of these infections is being challenged by increasing incidence of drug 
resistance and lack of effective vaccine (Croft et al., 2006; Fidock et al., 2008). 
Investigation of PCD pathways in these organisms might lead to discovery of novel 
parasite control strategies (Alvarez et al., 2008; Deponte and Becker, 2004). However, 
despite the many morphological and biochemical studies of PCD in protozoan 
parasites, most of the homologs of mammalian molecules involved in cell death 
signaling are missing in the protozoa and the molecular architecture of PCD in 
protozoan parasites therefore remains puzzling. 
 
The kinetoplastid parasites of the genera Leishmania and Trypanosoma cause 
different forms of leishmaniasis or trypanosomiasis such as Chagas disease (T. cruzi) 
and sleeping sickness (T. brucei). Different developmental stages of Trypanosoma 
and Leishmania have been shown to die with apoptotic or autophagic features by 
diverse triggering events (Debrabant et al., 2003). T. cruzi epimastigotes during in 
vitro differentiation exhibited cytoplasmic and nuclear morphological features of 
apoptosis (Ameisen et al., 1995). T. cruzi epimastigotes cell death could also be 
induced by human serum and inhibited by L-arginine-dependent synthesis of nitric 
oxide (Piacenza et al., 2001), whereas superoxide radicals resulted from 
mitochondrial calcium overload promotes human serum-induced cell death in T. cruzi 
and overexpression of mitochondrial super oxide dismutase had cytoprotective effects 
(Irigoin et al., 2009; Piacenza et al., 2007). Reactive oxygen species also induced 
PCD of procyclic forms of T. brucei by activating a calcium-dependent pathway 
because excess Ca2+ was observed in nucleus and Ca2+ chelators could inhibit DNA 
fragmentation (Ridgley et al., 1999). In this system, the nuclease activation was not a 
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consequence of serine protease, cysteine protease or proteasome activity nor did 
overexpression of Bcl-2 reverse mitochondrial dysfunction, so it was suggested that 
proteins involved in trypanosome PCD might be distinct from those in metazoans 
(Ridgley et al., 1999). In vitro cultures of T. brucei procyclic forms showed PCD 
features upon treatment with concanavalin A, a glucose- and mannose-specific lectin 
binding to glycoproteins (Welburn et al., 1996).  The proto-oncogene prohibitin and a 
receptor for activated protein kinase C was shown to be up-regulated in concanavalin 
A-induced cell death of T. brucei (Welburn and Murphy, 1998). Prostaglandin D2 and 
its derivatives can induce apoptosis-like PCD in T. brucei blood forms with increasing 
levels of intracellular reactive oxygen species (ROS), and pretreatment with low 
molecular weight antioxidants abolished formation of ROS, apoptotic features and 
inhibited cell death (Figarella et al., 2005; Figarella et al., 2006). 
 
Leishmania donovani exhibited apoptotic features in response to various stimuli, such 
as aging (Lee et al., 2002), oxidative stress (Das et al., 2001), antileishmanial drug 
amphotericin B (Lee et al., 2002) or the topoisomerase I inhibitor camptothecin (Sen 
et al., 2004). Autophagic cell death was observed when L. donovani was treated with 
antimicrobial peptides (Bera et al., 2003). L. major was found to succumb to the 
broad-spectrum protein kinase inhibitor staurosporine (Arnoult et al., 2002),  heat 
shock or serum deprivation (Zangger et al., 2002) with apoptotic features. The 
amastigote form of L. major died with DNA fragmentation when treated with nitric 
oxide, which could be produced by macrophages infected by the parasite (Zangger et 
al., 2002). Heat stress induced apoptotic-like death in L. infantum was found to be 
partially reversed by expression of the anti-apoptotic mammalian gene Bcl-XL (Alzate 
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et al., 2006) and mitochondrial superoxide was found to mediate this cell death 
(Alzate et al., 2007), suggesting an important role of mitochondria in this model.  
 
Apicomplexan protozoa of the genus Plasmodium cause malaria. It was found that the 
rodent parasite P. berghei undergoing differentiation from zygotes to ookinetes 
exhibited features typical of metazoan apoptotic cells including chromatin 
condensation, nuclear DNA fragmentation, exposure of phosphatidylserine (PS) from 
the inner to the outer layer of the cell membrane and caspase-like activity which was 
blocked by caspase inhibitors (Al-Olayan et al., 2002). Apoptotic like features were 
also observed in the human parasite P. falciparum blood stage cultures after treatment 
with the antimalarial drug chloroquine (Picot et al., 1997) or the apoptosis-inducer 
etoposide through a putative role of PfMCA1 metacaspase-like protein (Meslin et al., 
2007). However, as it might be difficult to analyze apoptotic markers in Plasmodium 
parasites (Deponte and Becker, 2004), some studies could not detect apoptotic 
markers during Plasmodium cell death (Nyakeriga et al., 2006), but observed 
secondary necrosis  (Porter et al., 2008) and autophagic-like cell death (Totino et al., 
2008).  
 
Trichomonads are amitochondrial parasites but possess hydrogenosome, an unusual 
anaerobic energy-producing organelle. T. vaginalis and T. foetus showed dramatic 
changes when treated with drugs and H2O2, including apoptotic features such as DNA 
fragmentation, exposure of PS in the outer leaflet of plasma membrane, 
hydrogenosomal membrane potential dissipation, and autophagic features such as an 
abnormal number of oversized vacuoles containing altered hydrogenosomes and 
misshapen flagella (Chose et al., 2002; Mariante et al., 2006). However, studies 
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related to trichomonads cell death are relatively few and more investigations are 
needed to understand how these parasites die without the known “mitochondrial cell 
death machinery” and the putative role of hydrogenosomes during cell death  (Chose 
et al., 2003). 
 
Blastocystis subtype 7 (previously known as B. hominis isolate B) underwent 
apoptosis-like death when treated with a cytotoxic monoclonal antibody (MAb 1D5) 
or the drug metronidazole (Nasirudeen et al., 2004; Nasirudeen et al., 2001b; Tan and 
Nasirudeen, 2005). Blastocystis cells displayed a number of morphological and 
biochemical features of apoptosis such as cell shrinkage and darkening, retention of 
plasma membrane integrity during initial stages of cell death, externalization of 
plasma membrane PS residues. DNA and nuclear fragmentation was also shown in 
situ although there was no DNA laddering pattern on agarose gels as seen in many 
apoptotic cells. Apoptotic bodies-like objects appeared to be deposited into the large 
central vacuolar space of the parasite by an invagination process (Nasirudeen et al., 
2004; Nasirudeen et al., 2001b; Tan and Nasirudeen, 2005). Caspase-3-like antigens 
and activity was detected during MAb 1D5-induced Blastocystis cell death; however, 
the identity of the caspase-3-like protein is still unknown (Nasirudeen et al., 2001a). 
Loss of mitochondrial membrane potential was noted in Blastocystis cell death 
(Nasirudeen and Tan, 2004). PCD that is independent of both caspase and 
mitochondria was also reported (Nasirudeen and Tan, 2005). On the other hand, 
ageing Blastocystis cells grown as colonies seemed to die with autophagic features, 




1.3.2 Implications of PCD in unicellular eukaryotes  
The existence of PCD in unicellular organisms may seem counterintuitive, as each 
cell can survive as an individual and the death of the cell means the death of an 
organism. However it has been suggested that unicellular organisms can organize 
themselves as populations and have intercellular communication (DosReis and 
Barcinski, 2001). A population of protozoan parasites infecting a host is usually 
founded by a single or a small number of individuals and most of the population share 
very similar or identical genetic information. Thus it is the entire parasite population 
of a host but not individual parasites that is subjected to evolutionary pressure 
(Bruchhaus et al., 2007). PCD may be useful in regulating the number of parasites to 
avoid damaging a host too early (Al-Olayan et al., 2002; Bruchhaus et al., 2007). 
PCD can also be a mechanism to control parasite growth under environmental 
pressure such as nutrient scarcity (Debrabant et al., 2003). Apoptosis-like death of 
parasites may avoid host inflammatory response leading to the killing of entire 
parasite population, and thus favour parasite evasion from the host immune system 
(Lee et al., 2002; Zangger et al., 2002).  
 
1.4 Objectives of the present study 
Despite increasing number of studies describing the cytochemical features of PCD in 
protozoan parasites, knowledge of the mechanism and molecular mediators of PCD in 
these unicellular organisms is very limited. Previous studies showed that Blastocystis 
succumbed to a cytotoxic monoclonal antibody MAb 1D5 by displaying features that 
are characteristic of apoptosis (Nasirudeen et al., 2001a; Nasirudeen et al., 2001b; 
Tan and Nasirudeen, 2005). MAb 1D5 was found to bind to a 30 kD protein of 
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unknown identity on the plasma membrane (Tan et al., 2001b; Tan et al., 1996a; Tan 
et al., 1997). The present study aimed to identify the cellular target of MAb 1D5 
through two dimensional gel electrophoresis and mass spectrometry based proteomic 
analysis followed by functional study of the protein. It is hoped that identifying and 
characterizing this protein would facilitate the discovery of cell death mechanisms in 
Blastocystis. 
 
It was reported that while DNA fragmentation was abolished, MAb 1D5-treated 
Blastocystis pre-exposed to zVAD.fmk and cyclosporine A was not rescued from cell 
death (Nasirudeen and Tan, 2004, 2005). Therefore, besides apoptosis, other cell 
death pathways might exist in Blastocystis and be triggered upon MAb 1D5 induction. 
In recent years, autophagic cell death (type II cell death) has received a lot of attention 
as an alternative PCD pathway (Baehrecke, 2005). The second part of the present 
study aimed to investigate if MAb 1D5 elicits alternative cell death pathway through 
autophagy and to characterize the autophagy phenomenon in Blastocystis. 
 
Different signaling pathways of PCD can be activated in the same cell in response to 
different stimuli (Taylor et al., 2008). Besides using cytotoxic antibody to induce 
PCD in Blastocystis, the present study also aimed to investigate if staurosporine, a 
common inducer of apoptosis in mammalian cells and the pathways of which has 
been extensively studied, can also elicit a PCD response in Blastocystis. Furthermore, 
by dissecting the mechanisms and regulation of the staurosporine-induced cell death 
pathway in Blastocystis may lead to discovery of novel mechanisms of PCD in this 
parasite. 
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Chapter 2  
Materials and Methods 
 
2.1 Culture of organism 
Blastocystis subtype 7 (previously known as B. hominis isolate B) was isolated from a 
local patient stool sample and axenized (Ho et al., 1993). Cells were cultured in 
Iscove’s modified Dulbecco’s medium (IMDM) containing 10% inactive horse serum 
and incubated anaerobically at 37 °C in an Anaerojar (Oxoid, UK).  Cells were 
subcultured at 3 to 4 days intervals and 4-day old cells at log-phase were used for all 
experiments. 
 
2.2 Preparation of monoclonal antibody (MAb) 1D5  
In this study, monoclonal antibody (MAb) 1D5, a surface-reactive IgM antibody, was 
used to induce PCD in Blastocystis. 
2.2.1 Hybridoma culture 
The hybridomas secreting MAb 1D5 were produced previously (Tan et al., 1996a). 
Briefly, three female BALB/c mice were immunized with 0.5 ml aliquots of the 
extract of Blastocystis subtype 7 (500 µg protein/ ml) emulsified in Freund’s complete 
adjuvant. Following booster immunization, spleen cells were harvests and fused with 
P3.X63.Ag8.U1 (P3U1) myeloma cells. The resultant hybridomas were selected by 
limiting dilution. Hybridoma cells were cryopreserved in IMDM containing 10% fetal 
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bovine serum in the presence of 5% dimethylsulfoxide (DMSO) and kept in liquid 
nitrogen tank in the Department of Microbiology, National University of Singapore. 
Cryopreserved hybridoma cells were thawed and cultured in IMDM supplemented 
with 10% fetal bovine serum. Culture supernatant was collected when the medium 
became acidic (orange to yellow in color) but before cells died and stored under 
sterile conditions at −20 °C. 
 
2.2.2 Purification of antibody 
MAb 1D5 was purified from hybridoma supernatants using Affiland Monoclonal IgM 
purification kit (Affiland S.A., Belgium). Briefly, 75 g of Precipitating Agent was 
added to 300 ml of hybridoma supernatant for 15 min with mild agitation. The 
mixture was allowed to stand for 30 min at 4 °C and spun at 3000×g for 10 min to 
collect the pellet. The pellet was dissolved in 30 ml of MAb IgM Binding Buffer and 
loaded to a pre-equilibrated Monoclonal IgM Binding Gel (SepharoseTM fast flow) 
column at a flow rate of 50 ml/h. MAb IgM Elution Buffer was used to elute MAb 
1D5 and the Optical Density (OD) of the eluent at 280 nm was monitored. Twenty-
one fractions of 2 ml eluent were collected (Figure 2.1 A) and 10 µl of each fraction 
was treated with β-mecaptoethanol, separated by SDS-PAGE and stained with 
Coomassie blue (Figure 2.1 B). Fractions A5 to A12 and B1 to B3 were protein 
containing fractions because of their high OD value (Figure 2.1 A) and also higher 
amount of proteins as seen on SDS-PAGE (Figure 2.1 B). To confirm these were 
indeed MAb 1D5, fraction A5 and A10 were checked by Western blotting using anti-
mouse Ig and the results showed two reactive bands of molecular weight 25 kD and 
50 kD, corresponding to the light chain and heavy chain of IgM. 
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Figure 2.1 Purification of MAb 1D5. A, OD plot of elution fractions. B, elution 
fractions were loaded onto 10% SDS-PAGE gels and stained with Coomassie blue. M, 
molecular weight marker (bands from top to bottom indicate 250, 150, 100, 75, 50, 37 
and 25 kD respectively).  C, elution fraction A5 and A10 were separated on a 10% 
SDS-PAGE gel and transferred to a PVDF membrane and probed with rabbit anti-
mouse Ig antibody.  
M  A1 A2  A3 A4  A5 A6  A7 A8  A9 A10  M A11 A12 B1  B2 B3  B4  B5  B6 B7   B8    M   B9   B10 B11 B12 C1
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Fractions A5 to A12 and B1 to B3 were pooled and the buffer of the eluant was 
changed to PBS and concentrated with a centrifugal filter unit (Amicon, Millipore). 
The protein concentration was assayed to be 16 µg/ml. The purified MAb 1D5 were 
stored at -20°C for experiments in this project and future use.  
 
2.3 2-D proteomics 
2.3.1 Sample preparation 
Blastocystis cells were collected by centrifugation at 2000×g for 10 min and washed 
three times with 1×PBS (137 mM NaCl, 2.7 mM KCl, 2 mM KH2PO4, 10 mM 
Na2HPO4). The final cell pellet was stored at -80 °C until further use. HALT Protease 
Inhibitor Cocktail, EDTA-free (Pierce) was added to the cell pellet before cells were 
lysed. The cell pellet was treated with different sample preparation methods. 
 
Method 1 Freeze-thaw 
Cell pellet was resuspended in equal volume of PBS with protease inhibitor cocktail. 
The suspension was subjected to three cycles of alternate freezing (2 min in liquid 
nitrogen) thawing (37˚C water bath) and centrifuged at 16000×g for 10 min at 4 °C. 
 
Method 2 Triton-X100 
Cells were lysed by 0.5% (v/v) Triton-X100 in the presence of protease inhibitor 
cocktail and allowed to sit on ice for 30 min with occasional shaking. 2-D sample 
buffer (7 M urea, 2 M thiourea, 4% CHAPS, 50 mM DTT, 0.2% Bio-lyte® 3/10 
ampholytes, 0.02% bromophenol blue) was added to the lysate for 10 min on ice, and 
clear supernatant was collected after centrifugation at 16000×g for 10 min at 4 °C. 
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Method 3 Trichloroacetic acid (TCA) precipitation 
Cell pellet was subjected to three cycles of freezing and thawing. Total proteins from 
clear cell lysate were precipitated by adding 100% (w/v) TCA to sample so that the 
final TCA concentration is 10% (w/v). The precipitation process was carried out at 
4 °C for 2 h and protein pellet was collected by centrifugation at 16000×g for 15 min 
at 4 °C. The pellet was washed twice with ice-cold acetone and allowed to air dry at 
room temperature. 
 
Method 4 DOC-TCA precipitation 
Lysates from freeze-thawed parasites was mixed with 1/100 of its volume of 2% DOC 
(sodium deoxycholate), incubated on ice for 30 min, and 100% (w/v) TCA was added 
to bring the sample to a final TCA concentration of 10% with immediate vortex. The 
sample was sat on ice for 2 h to precipitate proteins and protein pellet was collected 
by centrifugation at 16000×g for 15 min at 4 °C. The pellet was washed twice with 
ice-cold acetone and allowed to dry at room temperature. 
 
Method 5 TCA/acetone precipitation 
To 1 volume of freeze-thawed parasite lysates, 8 volumes of 11.3% (w/v) 
TCA/acetone was added to bring the final concentration of TCA to 10% (w/v). 
Protein precipitation was carried out at -20 °C for 2 h and protein pellet was collected 
by centrifugation at 16000×g for 15 min at 4 °C. The pellet was washed twice with 
ice-cold acetone and air dried at room temperature. 
 
Method 6 Chloroform/MeOH precipitation 
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To 1 volume of freeze-thawed parasite lysates, the following reagents were added 
sequentially with vortexing: 4 volumes of methanol, 1 volume of chloroform and 3 
volumes of water. After centrifugation at 16000×g for 2 min, aqueous top layer was 
removed and 4 volumes of methanol were added with vortexing. Protein pellet was 
collected by centrifugation of the mixture at 16000×g for 2 min and air dried at room 
temperature.  
 
Following each method described above, sample buffer (7 M urea, 2 M thiourea, 4% 
CHAPS, 50 mM DTT, 0.2% Bio-lyte® 3/10 ampholytes, 0.02% bromophenol blue) 
was added to the solution or pellet. Protein concentration was estimated by a modified 
Coomassie Plus protein assay kit (Pierce) with BSA as standard because urea found in 
the lysis solution is a compound that interferes with protein estimation. 
 
2.3.2 2-D electrophoresis 
For 2-D electrophoresis in mini gel format, 200 µg proteins in 125 μl of 2-D sample 
buffer were loaded into a 7 cm immobilized pH gradient (IPG) strip (Bio-Rad). After 
active rehydration for 12 h at 50 V, isoelectric point focusing (IEF) was performed in 
a Bio-Rad Protean IEF Cell under the following conditions: linear voltage ramp to 
150 V over 20 min; linear voltage ramp to 300 V over 20 min; linear voltage ramp to 
600 V over 20 min; linear voltage ramp to 1200 V over 1 h; linear voltage ramp to 
4000 V over 1.5 h; 4000 V for 12000 Vh. The IEF was performed at 20 °C at a 
maximum of 50 mA per strip. For big gel 2-D electrophoresis, 550 µg proteins in 
300 μl of 2-D sample buffer were loaded into a 17 cm IPG strip. Active rehydration 
was carried out in Bio-Rad Protean IEF Cell for 12 h at 50 V, followed by IEF using 
the following parameters: linear voltage ramp to 250 V over 30 min; linear voltage 
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ramp to 500 V over 1 h; linear voltage ramp to 2500 V over 1.5 h; linear voltage ramp 
to 10000 V over 2.5 h; 10000 V for 40000 Vh. After IEF, IPG strips were soaked in 
equilibration buffer (6M urea, 2% SDS, 0.375 M Tris-HCl pH 8.8, 20% glycerol) 
supplied with 2% (w/v) DTT for 15 min and then in equilibration buffer containing 
2.5% (w/v) iodoacetamide for 15 min. IPG strips of 7 cm length were then mounted 
onto a precast 8-16% Bio-Rad Ready Gel® using Easymelt agarose (Bio-Rad) and 
second dimension electrophoresis was performed in Bio-Rad Mini-PROTEAN® 3 
electrophoresis cell at constant voltage of 200 V. IPG strips of 17 cm length were 
mounted onto home-made 12% Laemmli SDS-PAGE gel (18×16 cm) and second 
dimension electrophoresis was performed in Bio-Rad Protean II xi electrophoresis cell 
at 16 mA/gel for 30 min and then 24 mA/gel for another 6 h at 4°C. Gels were stained 
using Coomassie Brilliant Blue (CBB). Stained gels were scanned with Bio-Rad GS-
800 densitometer and analyzed with PD Quest 7.1 software (Bio-Rad). 
 
2.3.3 In-gel protein digestion and protein identification by MALDI-TOF mass 
spectrometry 
Protein spots were manually excised from Coomassie blue-stained 2-D gels and were 
in-gel digested with trypsin. Briefly, gel pieces were soaked in 50% (v/v) acetonitrile 
(ACN) with 50 mM ammonium bicarbonate (NH4HCO3) and incubated at 37 °C for 
30 min to wash off the stain. The gel spots were then dried in Speedvac vacuum 
centrifuge (Savant Instruments) for 5 min. A digestion solution of 3.3 ng/µl 
sequencing grade modified trypsin (Promega) in 50 mM NH4HCO3 was added to the 
dried gel piece and incubated at 37 °C overnight. Peptides were extracted using 0.1% 
(v/v) trifluoroacetic acid (TFA; Sigma) in 50% ACN, sonicated at 37 °C for 10 min 
and then dried in a Speedvac evaporator. Peptides were mixed with an equal volume 
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of CHCA matrix solution (5 mg/ml α-cyano-4-hydroxycinnamic acid in 0.1% TFA, 
50% ACN) and spotted onto a 384-well MALDI sample plate (384 opti-TOF, ABI) 
followed by air-drying. MS and MS/MS (10 most intense ions from each sample were 
selected for MS/MS) analyses were carried out using the ABI 4800 MALDI-
TOF/TOF Mass Spectrometer (Applied Biosystems). Peptides derived from trypsin 
were used as an internal standard. Data from MS and MS/MS acquisitions were used 
in a combined search against the NCBI nonredundant protein database and an in-
house Blastocystis in silico translated protein database using MASCOT (Version 2.1; 
Matrix Science, London, UK). Mascot scores greater than 54 were considered to be 
significant (p<0.05).  
 
The genomic sequence contigs of Mascot hits were retrieved. The program 
GENSCAN was used to predict the locations and exon-intron structures of genes in 
genomic sequence contigs (http://genes.mit.edu/GENSCAN.html). Parameters used 
were Arabidopsis for organism and suboptimal exon cutoff of 1.00. In case of 
multiple genes predicted within the same contig, the most probable gene for the 
chosen protein spot was verified by the presence of matched peptides. The predicted 
protein sequence was searched against the Blastocystis EST database 
(http://tbestdb.bcm.umontreal.ca/searches/organism.php?orgID=BH) stored locally 
using StandAlone Basic Local Alignment Search Tool (BLAST) version 2.2.18. 
 
2.4 Western blotting 
Two-dimensional gel electrophoresis was carried out as described in section 2.3.2. For 
one-dimensional sodium dodecylsulphate-polyacrylamide gel electrophoresis (1D 
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SDS-PAGE), Blastocystis cells were lysed in buffer (25 mM TRIS pH 7.5, 150 mM 
NaCl, 0.1% Triton X-100, 1 mM DTT, 1 mM EDTA, 1 mM EGTA, 10 mM NaF, 20 
mM β-glycerophosphate, 1 mM Na3VO4, Roche complete protease inhibitor) and the 
soluble fraction obtained by centrifugation (16000×g, 10 min) at 4 °C. Total protein 
concentration was estimated by Bradford assay, and 50 µg of total protein or 5 µg of 
purified protein was electrophoresed on a 10% SDS-PAGE gel. Following 1-D or 2-D 
electrophoresis, proteins were transferred onto a PVDF membrane (GE Healthcare) 
by semi-dry blotting (Bio-Rad), blocked with 3% BSA in TBS-T (triethanolamine-
buffered saline with 0.1% Tween 20), incubated with primary antibody, washed, 
incubated with secondary antibody and visualized by chemiluminescence (ECL plus, 
GE Healthcare) and exposed to an X-ray film (Kodak). 
 
2.5 Comparison of sequences 
The catalytic domain and C-terminal extension of Blastocystis legumain was 
amplified by PCR from a constructed cDNA library of Blastocystis subtype 7. 
Conceptual translation of the nucleotide sequence had 330 amino acids and the 
sequence was submitted to GenBank (accession number: ACO24555). Sequences of 
legumains from other species were retrieved from GenBank as the following: mouse 
(NP_035305), rat (NP_071562), human (AAH03061), bovine (NP_776526), frog 
(NP_001005720), zebra fish (NP_999924), Schistosoma (CAB71158), rice 
(BAC41386), tobacco (CAE84598), Haemonchus (CAJ45481) and Trichomonas 
(AAQ93040). Multiple sequence alignment was performed with ClustalW search 
engine and manually refined with program Vector NTI (Invitrogen). 
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2.6 Biochemical characterization of recombinant legumain 
2.6.1 pH optimum for enzymatic activity 
To measure the pH optimum of Blastocystis legumain enzymatic activity, purified 
recombinant legumain (10 µg) was placed in wells of a 96-well microplate. The 
reaction was started by adding legumain specific substrate Z-Ala-Ala-Asn-NHMec 
(finial concentration 10 µM) in assay buffers of different pH supplemented with 
1 mM dithiothreitol, 1 mM EDTA and 0.1% CHAPS. The series of buffers used were: 
50 mM citric acid-sodium citric, pH 3, pH 4, pH 5; 50 mM MES, pH 5.5, pH 6, pH 
6.5; 50 mM Tris-Cl, pH 6.8, pH 7, pH 7.5, pH 8, pH 8.8. The plate was incubated at 
30 °C for 30 min. Readings of fluorescence (excitation 353 nm; emission 442 nm) 
was taken by a TECAN fluorescence plate reader. Results were corrected by 
substracting the value obtained with legumain-heated inactive control.  
 
2.6.2 Pharmacological inhibitors of enzymatic activity 
Purified recombinant legumain was tested for its enzymatic activity in the presence of 
different inhibitors. The activity assay was carried as described in the previous section 
with PBS as reaction buffer. Inhibitors used were MAb 1D5 (1.2 μg/ml); non-specific 
IgM control (2 μg/ml); legumain-specific inhibitor Cbz-Ala-Ala-AAsn-RR-COOOEt 
(APE-RR, 1 mM); Z-Ala-Ala-Asn-NHMec (10 μM); cystatin (200 μg/ml); caspase-1 
inhibitor Ac-YVAD-CMK (4 μM); and cathepsin B inhibitor Z-FA-FMK (400 μM).  
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2.7 Subcellular localization of legumain by immunofluorescent staining 
Cells (1×107) were washed with cold PBS and incubated in IMDM medium 
containing 5 μg fluorescein diacetate (FDA) at 37 °C for 10 min. Cells were then 
washed and fixed with 3.7% (v/v) formaldehyde on ice for 30 min. To permeabilze 
cell, cell were incubated with 0.1% Trixton X-100 for 5 min. Cells were incubated 
with primary antibody (MAb 1D5 or anti-legumain, 1.2 μg/ml in PBS containing 3% 
BSA) for 2 h at room temperature, washed and incubated with AlexaFluor 594-
conjugated secondary antibody (anti-mouse IgM or anti-goat IgG, 2 μg/ml in PBS 
containing 3% BSA) for 1 h at room temperature. The cells were washed and stained 
with DAPI and viewed using a confocal microscope (Olympus FV500). 
 
2.8 Apoptosis detection assay 
2.8.1 Annexin V-FITC and PI staining 
Membrane permeability and exposure of phosphatidylserine (PS) were analyzed using 
an Annexin V-FITC apoptosis detection kit (BioVision). In brief, cells were washed 
with cold PBS and resuspended in 500 μl calcium-containing binding buffer. Five 
micro liter of Annexin V-FITC and propidium iodide (PI) each were added to the cell 
suspension and incubated at room temperature for 10 min. The cells were washed, re-
suspended in 500 μl of PBS and analyzed by a flow cytometer (DAKO CyAn ADP) 
with 488 nm argon-ion laser.  Annexin V-FITC was detected using an emission filter 
of 530-540 nm and PI was detected using an emission filter of 613-620 nm. 
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2.8.2 TUNEL assay  
Terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) 
was performed using APO-BrdU kit (Invitrogen). In brief, cells were harvested, 
washed with cold PBS and fixed with 1 ml 3.7% (v/v) formaldehyde on ice for 30 min. 
After two washes with PBS, the pellet was re-suspended in 1 ml of 70% cold ethanol 
at -20 °C for 30 min to permeabilize cells. The cells were washed and incubated with 
50 μl labeling solution containing 5 ‑ bromo ‑ 2’ ‑ deoxyuridine 5’ ‑ triphosphate 
(BrdUTP) and terminal deoxynucleotidyl transferase at 37 °C for 1 h. After rinsing, 
cells were stained with AlexaFluor 488 conjugated anti-BrdU antibody at room 
temperature for 30 min. The cells were washed, re-suspended in 500 μl of PBS and 
analyzed by a flow cytometer (DAKO CyAn ADP) using a 488 nm argon-ion laser. 
Green fluorescence was detected using an emission filter of 530-540 nm. 
 
2.9 Autophagy detection assay 
2.9.1 Cell treatments 
Blastocystis cells were subjected to various treatments for the assessment of 
autophagy.  
 
For MAb 1D5 treatment, cells were pre-treated with 50 µM zVAD.fmk and/or 10 µM 
cyclosporine A for 30 min, and were then exposed to MAb 1D5 or non-specific IgM, 
and incubated anaerobically for 24 h at 37 °C.  
 
To test for the presence of autophagy in Blastocystis colonies, cells were grown in 
soft agar as previously described (Tan et al., 1996b) with minor modifications. 
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Approximately 1 × 104 cells taken from day 4 log-phase cultures were mixed in 1 ml 
of IMDM, added to 20 ml of the mixture of 0.36% Bacto agar and 0.1% sodium 
thioglycollate in IMDM supplemented with 10% horse serum at 40 °C, and poured 
into a 100 × 15 mm Petri dish (Nunclon). After gentle swirling to ensure good 
separation of cells, the Petri dish was kept at -20 °C for 10 min to allow the agar to set 
and then incubated in an anaerobic jar at 37 °C for 10 days. 
 
For amino acid starvation, 1 × 107 Blastocystis cells washed three times with PBS and 
incubated in 5 ml of Hank's Buffered Salt Solution (HBSS). The tubes were then 
incubated anaerobically at 37 °C for different time intervals (1, 2 or 3 h).  
 
Rapamycin treatment was done by incubating 1 × 107 Blastocystis cells with 100 nM, 
500 nM or 1000 nM rapamycin (Sigma) in 5 ml IMDM supplemented with 10% horse 
serum and were incubated anaerobically at 37 °C for 3 h. DMSO control was also 
included.  
 
To test the effect of the autophagy inhibitors 3-MA and wortmannin on Blastocystis, 
cells were pre-treated with 20 mM 3-MA (Sigma) or 50 µM wortmannin, and were 
incubated for 3 h prior to exposure to MAb 1D5, amino acid starvation or rapamycin 
treatment as described above. 
 
2.9.2 Monodansylcadaverine (MDC) staining 
Following various treatments, cells in liquid culture were spun down, washed once 
with PBS and resuspended in 500 μl PBS. Then 10 μl of 5 mM MDC (Fluka) in PBS 
was added to the suspension and incubated at 37°C for 15 min. After incubation, the 
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cells were washed thrice with PBS and mounted onto glass slides with coverslips. 
Cells were then visualized with a fluorescence microscope (Olympus BX60) using 
excitation filter of 360 nm and emission filter of 525 nm. The images were captured 
by a CCD camera (Olympus DP70). The percentage of MDC positive cells were 
determined by scoring 500 cells per group. 
 
To stain colony cultures of Blastocystis, colonies embedded in the agar were removed 
by a sterile inoculating loop and stained with 0.05 mM MDC in PBS for 30 min. After 
which, the colonies were washed in 1 ml PBS twice with 5 min interval between each 
wash. The colonies were then placed on a slide and pressed gently with a coverslip. 
The colonies were viewed under fluorescent microscope to examine the uptake of the 
stain by cells at the center and periphery of the colony.  
 
2.9.3 Confocal microscopy examination of MDC and Lysotracker Red costaining 
Following various treatments, the cell pellet was stained with 0.05 mM MDC for 15 
min at 37 °C and then with 50 nM Lysotracker Red DND-99 (Molecular Probes) for a 
further 30 min at 37 °C. After incubation, the cells were washed thrice with PBS and 
mounted onto glass slides with coverslips. Fluorescent images were obtained by using 
a confocal microscope (Olympus Fluoview FV500). MDC was excited at 405 nm, and 
emission was collected in the 505 nm to 525 nm bands and Lysotracker was excited at 
543 nm, and emission was collected in the 584 nm to 654 nm bands. 
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2.10 Transmission electron microscopy (TEM) 
The ultrastructural features of Blastocystis cells under various treatments were 
examined using transmission electron microscopy. Briefly, cells were fixed with 2% 
glutaraldehyde and 2% paraformaldehyde in PBS for 3 h at 4 ºC. The cells were then 
pelleted at 1000×g for 5 min, washed twice with PBS and twice with deionized water. 
After each washing step, cells were spun at 1500×g and the supernatant was discarded. 
Cells were then postfixed for 2 h with 1% osmium tetroxide containing 1% potassium 
ferro-cyanide at room temperature and dehydrated with graded ethanol series (25%, 
50%, 75%, 95% and 100%). Infiltration of embedding media was done by passing 
cells through three changes of mixtures of ethanol and the embedding media (LR 
White resin), and four changes of absolute LR White embedding media. After the last 
change of LR White, cells were resuspended in 100 – 200 µl LR White. The 
suspension was then transferred to a BEEM capsule and centrifuged at 1500×g for 15 
min to collect the cells at the bottom tip of the capsule. Capsules were then incubated 
for 48 h at 50ºC to allow polymerization of the embedding media. Cells were 
embedded into a microtome (Reichert-Jung) and sliced into 90 nm sections. Ultrathin 
sections were collected on a 200 mesh copper grid, stained with uranyl acetate and 
lead citrate each for 9 min and examined using an EM208S transmission electron 
microscope (Philips). 
 
2.11 Treatment with staurosporine to induce cell death 
Staurosporine (Sigma) was used to induce cell death in Blastocystis. Cells were 
inoculated into IMDM in a concentration of 2×106 cells per ml. Staurosporine (1 mM 
stock in DMSO, Sigma) was then added to a final concentration of 1 µM and 
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incubated with cells for 3 h or 12 h for flow cytometry analysis (as described in 
section 2.8) and ultrastructural studies (as described in section 2.10). Necrotic control 
was done by heating cells at 80 ºC for 15 min. The effect of protease inhibitors or 
cyclosporine A on staurosporine-induced cell death was tested by addition of protease 
inhibitors or cyclosporine A 30 min before the addition of staurosporine. The protease 
inhibitors used were: N-Benzyloxycarbonyl-Val-Ala-Asp(O-Me) fluoromethyl ketone 
(z-VAD.fmk); Z-Phe-Ala fluoromethyl ketone (z-FA.fmk); Z-Phe-Phe-fluoromethyl 
ketone (z-FF.fmk); (L-3-trans-(Propylcarbamyl)oxirane-2-carbonyl)-L-isoleucyl-L-
proline methyl ester (CA-074Me); Z-Leu-Leu-Leu-fluoromethyl ketone (z-LLL.fmk); 
N-acetyl-L-leucinyl-L-leucinyl-L-norleucinal (ALLN); epoxomicin; (2S,3S)-trans-
Epoxysuccinyl-L-leucylamido-3-methylbutane ethyl ester (E64D) (all were obtained 
from Sigma, diluted in DMSO, and used at 50 µM unless otherwise stated). 
Iodoacetamide was purchased from Bio-Rad and diluted in water. Cyclosporine A 
(Sigma) was diluted in DMSO and used at 10 µM. 
 
2.12 Calpain activity assay 
The calpain activity assay was performed using the Calpain Activity Assay Kit 
(Biovision) according to the manufacturer’s protocol. Briefly, cells were treated with 
staurosporine for 3 h in the presence of different inhibitors. An equivalent number of 
cells (2 × 106) were pelleted, and the pellets resuspended and incubated in the 
supplied extraction buffer on ice for 20 min. After a brief centrifugation at 10000×g 
for 1 min, the clear lysates were transferred to a 96-well microplate, mixed with a 
fluorogenic calpain substrate Ac-LLY-AFC and incubated for 1 hour at 37 °C in the 
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dark. Fluorescence intensity was determined at 400 nm excitation and 505 nm 
emission by a TECAN fluorescence plate reader. 
 
2.13 Reproducibility of results and statistical analysis 
All experiments were repeated at least twice, except for transmission electron 
microscopy analysis, which was performed once. Quantitative data were statistically 




Mechanisms of MAb 1D5-Induced PCD in Blastocystis 
 
3.1 Identification of legumain as MAb 1D5 targeted protein through 2-D 
proteome analysis 
The total set of proteins expressed from the genome of the cell at a given time is 
called the proteome (Anderson and Anderson, 1998). Two-dimensional gel 
electrophoresis (2-DE) is a powerful and most commonly used method for proteomic 
analysis (Gorg et al., 2004; O'Farrell, 1975). Complex protein mixtures extracted 
from cells and tissues can be separated first according to their isoelectric point and 
then by molecular weight. Thousands of protein spots can be separated on a 2-D gel in 
a highly reproducible manner. Unknown proteins of interest can be excised from the 
gel and digested by trypsin followed by mass spectrometric analysis giving a pattern 
of digested peptides which can be matched to the theoretical patterns derived from 
known protein databases and thus the identity of the unknown protein can be 
ascertained (Gorg et al., 2004). 
 
3.1.1 Optimization of sample preparation for 2-D proteomics 
The choice of a suitable sample preparation method is of ultimate importance for a 
successful 2-DE analysis of the proteome and has to be adapted and optimized for 
specific cells and tissues (Shaw and Riederer, 2003; Weiss and Gorg, 2008). Most 
sample preparation protocols consist of a two-step process: cell disruption and 
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solubilization of proteins. Some samples may require an in-between step to remove 
interfering compounds.  
 
In the initial trial of sample preparation, Blastocystis cells were disrupted by freeze-
thaw cycling or by detergent lysis using Triton X-100 and protein solubilization was 
carried out in a commonly used 2-D sample buffer consisting of chaotropes (7 M urea 
and 2 M thiourea), zwitterionic detergent (4% CHAPS), reducing agent (50 mM DTT), 
and carrier ampholytes (0.2% Bio-lyte® 3/10 ampholytes). The protein samples were 
separated in the first dimension on a 7 cm IPG strip and in the second dimension on 
an 8-16% gradient mini gel. As visualized by Coomassie blue staining (Figure 3.1.1), 
only a minimal amount of proteins were resolved at the acidic and lower molecular 
weight region. The scarcity of resolved protein spots may be due to poor 
solubilization of proteins or impeded entry of proteins to IPG strips caused by 
interfering compounds. Horizontal streaks seen on the gels also indicated incomplete 























Figure 3.1.1 Coomassie blue-stained 2-D gels of Blastocystis. Cells were subjected to 
freeze-thaw cycling (A) or Triton-X 100 lysis (B) and then solubilized in 2-D sample 
buffer. Extracted proteins were then separated by IEF in the first dimension using a pI 
4-7 gradient IPG strip followed by 8-16% gradient SDS-PAGE gel in the second 
dimension. 
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Precipitation is the most common method to separate proteins from contaminants in 
the sample and to concentrate proteins. Four precipitation methods, namely TCA 
(trichloroacetic acid) precipitation, DOC (sodium deoxycholate)-TCA precipitation, 
TCA/acetone precipitation and chloroform/methanol precipitation, were evaluated 
using mini-gel format 2-D electrophoresis in order to choose the most reliable one for 
the best protein separation. With regard to the concern of protein loss during 
precipitation and the consequent washing, it was found out through Bradford assay 
that the various precipitation methods were equally satisfactory and at least 70% of 
the protein levels in crude lysates were recovered in each case. Figure 3.1.2 shows the 
representative results of 2D electrophoresis analysis by the four different precipitation 
methods. The TCA/acetone precipitation method (Figure 3.1.2 A) constantly yielded 
the most satisfactory result because the protein spots were best resolved. DOC-TCA 
precipitation (Figure 3.1.2 B) performed well to resolve proteins at the acidic region, 
but proteins near the neutral region were missing in the precipitate. TCA precipitation 
alone (Figure 3.1.2 C) was not as effective as the combination of TCA and acetone 
based on the observation of a great amount of horizontal streakings. 
Chloroform/methanol precipitation (Figure 3.1.2 D) appeared to fail in removing 
interfering compounds from Blastocystis proteins, since proteins did not enter IPG 
strip as effectively as the other three precipitation methods and the resulted 2D gel 
was virtually blank. Thus, the method of choice for precipitation of Blastocystis 
proteins is using TCA/acetone because of its good quality, reproducibility and 
















































Figure 3.1.2 Two-dimensional electrophoresis analyses of Blastocystis cell lysates 
following precipitation with TCA (A), DOC-TCA (B), TCA/acetone (C), and 
chloroform/methanol (D). In each case, 200 µg of solubilized protein was loaded to a 
pI 4-7 gradient IPG strip (7 cm) and separated by IEF in the first dimension followed 
by 8-16% gradient SDS-PAGE gel in the second dimension. The gels were stained 
with Coomassie blue. 
 
3.1.2 Construction of 2-D proteome map of Blastocystis subtype 7 
Having established a standardized and reproducible method for the preparation of 
Blastocystis proteins for 2-D electrophoresis, a 2-D proteome map was created for 
Blastocystis subtype 7 (Figure 3.1.3). Proteins of Blastocystis subtype 7 vacuolar 
forms were precipitated using TCA/acetone, resolubilized and separated on 4-7 linear 
and 3-10 linear immobilized pH gradient strips of 17 cm length. The second 
dimension was separated on a 12% acrylamide gel. Coomassie blue-stained gels 
showed protein spots with a wide range of molecular weights, isoelectric points and 
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relative intensities. It was observed that majority of separated proteins had isoelectric 
points between pH 4 and 8.  
 
The number of protein spots was counted using the PDQuest software. A total of 1134 




Figure 3.1.3 2D gels of TCA/acetone precipitated Blastocystis cell extracts, separated 
by IEF in 17 cm IPG strips in the pH range 4-7 (A) and 3-10 (B), followed by 
separation in the second dimension using 12% SDS-PAGE gels. Protein detection was 
by Coomassie blue staining.  
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3.1.3 Identification of some landmark protein spots 
Sixteen protein spots (Figure 3.1.4) were excised and digested with trypsin. Their 
mass spectra were acquired with MALDI-TOF-TOF MS and the peak list was 
submitted for database searching using Mascot program against an in-house database 
of in silico translated draft genome database of Blastocystis. The sequence contigs of 
significant matches were retrieved and putative genes were predicted using 
GENESCAN program. The putative coded proteins were searched against NCBI 
Conserved Domain Database and the Blastocystis EST database to provide the 
possible functions of these proteins (Table 3.1.1). It was found that several clearly 
resolved spots appeared to be encoded by the same genes, such as spot 1 and 2, spot 5 
and 6, and spot 7 and 8, which may be due to different posttranslational modifications. 
The identified proteins have various cellular functions. There are metabolic enzymes 
involved in different metabolic pathways, such as lipid metabolism (long-chain acyl-
CoA synthetases, acyl-CoA synthetase, acetyl/propionyl-CoA carboxylase), amino 
acid metabolism (urocanate hydratase, and aminoacyl-histidine dipeptidase), and 
nucleotide metabolism (IMP dehydrogenase). Three protein spots (spot 13, 14 and 15) 
were found to belong to the C1 cysteine protease family. Other identified proteins 
have roles in protein synthesis (EF-2), vesicular trafficking (Rab), regulation of 
intracellular calcium homeostasis (calreticulin) and interaction with cytoskeletal 






























Figure 3.1.4 2-D electrophoresis map of Blastocystis proteins identified by mass 





























Annotation of EST 
1 47 4.35 Contig 0187 132 Calreticulin BHL00002741 Calreticulin domain containing 
protein 
2 44 4.4 Contig 0187 163 Calreticulin BHL00002741 Calreticulin domain containing 
protein 
3 100 4.8 Contig 1593 329 Calponin homology 
domain 
BHL00003062 Calponin homology domain 
protein 







long chain acyl-CoA 
synthetase 
5 90 5.9 Contig 2221 114 Acyl-CoA synthetase BHL00001756 Acetyl-CoA synthetase 
6 90 6 Contig 2221 165 Acyl-CoA synthetase BHL00001756 Acetyl-CoA synthetase 
7 75 6.2 Contig 1903 490 Acetyl/propionyl-CoA 
carboxylase, alpha subunit  
 
BHL00001817 Propionyl-CoA carboxylase 
alpha chain, mitochondrial 
precursor related cluster 
8 75 6.3 Contig 1903 485 
 
Acetyl/propionyl-CoA 
carboxylase, alpha subunit 
 
BHL00001817 Propionyl-CoA carboxylase 
alpha chain, mitochondrial 
precursor related cluster 
        






















Annotation of EST 
9 70 6.3 Contig 1865 368 Urocanate hydratase 
[Amino acid transport and 
metabolism] 
BHL00001712 Probable urocanate hydratase 
related cluster 
10 45 6.2 Contig 1990 77 Inosine-5-monophosphate 
dehydrogenase (IMP  
dehydrogenase) 
BHL00001840 Inosine-5-monophosphate 
dehydrogenase 1 related 
cluster 
11 60 5.7 Contig 2160 136 aminoacyl-histidine 
dipeptidase 
BHL00001818 Aminoacyl-histidine 
dipeptidase related cluster 
12 30 6 Contig 2380 107 EF-2 BHL00000235 T6H22.13 elongation factor 2, 
putative / EF-2, putative 
[EC:3.6.5.3] [KO:K03234] 
13 29 4.7 Contig 1743 347 Peptidase_C1A_Cathepsin
X 
BHL00001238 Cathepsin Y related 
cluster/Cathepsin Z precursor 
related cluster 
14 28 4.6 Contig 2138 80 Cathepsin B group BHL00000346 Cathepsin B precursor related 
cluster 
15 17 4.35 Contig 1531 98 Peptidase C1 family  
and, 
Cathepsin propeptide 
inhibitor domain (I29) 
BHL00000315 Cysteine protease related 
cluster 
16 12 5.2 Contig 2304 54 Rab subfamily of small 
GTPases 
BHL00001604 Rab family GTPase Rab8 
related cluster 
* Protein scores greater than 54 are significant (p<0.05)
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3.1.4 Identification of legumain as MAb 1D5 targeted protein 
To identify the MAb 1D5 targeted protein(s), Blastocystis proteins were separated by 
2-D electrophoresis and transferred to a PVDF membrane which was subsequently 
probed with MAb 1D5 for immunoblot analysis. In the broad range pI 3-10 gel blot 
(Figure 3.1.5 A, left) one prominent and big spot could be visualized after film 
developing, and there were some fainter spots in the pI range of 4 to 7. The narrow 
range pI 4-7 gel blot (Figure 3.1.5 A, right) separated these spots better, and it was 
observed that besides the prominent big spot (arrow pointed), MAb 1D5 also 
recognized a tiny spot (dashed arrow pointed). All the other fainter spots were likely 
to be nonspecific binding of MAb 1D5 or the secondary antibody because their 
intensity was much lower. The Western blot was matched against CBB stained 2-D 
gel, and the big spot was found to be matched to three close spots of the same 
molecular weight but different pI. The molecular weight of the three spots was 30.5 
kD, consistent with 1-D Western blot result from previous studies (Tan et al., 1996a; 
Tan et al., 1997).  pI value of the three spots were 4.55, 4.6 and 4.75. It was likely that 
because the chemiluminescence signal was very strong so the three spots appeared as 
one in the Western blot. However, the attempt to match the tiny spot to CBB stained 
2-D gel was failed because the protein spot distribution in nearby region was complex 
and the original spot may be of low quantity to be detected by CBB staining. Using a 
micro-range of IPG strip (pI 4.7-5.9) might help to better resolve proteins in this 
region and to locate this spot. 
 
The three MAb 1D5 reactive protein spots were excised from CBB stained 2-D gel, 
digested by trypsin and analyzed by MALDI-TOF mass spectrometry (Figure 3.1.6). 
Base peaks of the three spots were all 1540, suggesting that the three spots had the 
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same most intense ion. The rest of mass peaks of mass-to-charge ratio (m/z) were also 
highly identical among the three samples. Therefore, the three spots should represent 
the same protein with slightly different charges. 
 
Individual peaks from the mass spectrum were further analyzed by tandem mass 
spectrometry (MS/MS) and seven tryptic peptides were sequenced in total (Table 
3.1.2). 
 
Table 3.1.2 MS/MS sequenced peptide of MAb 1D5 reactive protein 
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Figure 3.1.5 Identification of MAb 1D5 targeted protein by Western blotting of 2D 
electrophoresis gel. A, Western blot analysis of total proteins separated on pH3-10 
range (left) and pH4-7 range (right) IPG strips probed with MAb 1D5. One prominent 
and big spot could be visualized (arrow) and there was also a tiny spot (dashed arrow). 
B, a Coomassie blue (CBB) stained 2D electrophoresis gel area matched with 
immunoblot probed by MAb 1D5. The prominent big spot on the blot (black arrow) 
was matched to three close spots (white arrows) on the CBB stained gel, which were 









Figure 3.1.6 Mass spectrum of MAb 1D5 reactive protein spots from Figure 3.1.5 B 
(A, spot 1; B, spot 2; C, spot 3). The spots were excised from Coomassie blue stained 


















































































































































































































































































































































































































































































Mascot searches of the acquired peptide mass fingerprinting results against the in-
house Blastocystis database showed an excellent match with Contig 1466. Three 
genes were predicted in this genome sequence contig by the program GENSCAN 
(http://genes.mit.edu/GENSCAN.html) (Figure 3.1.7; Appendix I). One predicted 
gene (gene 2 in Figure 3.1.7 A) was found to cover all the seven sequenced peptides 
of MAb 1D5 target protein (Figure 3.1.7 B). Therefore, MAb 1D5 targeted protein 
should be encoded by this putative gene. Conserved domain analysis of the putative 
gene showed a complete peptidase C13 domain and incomplete NIF (NLI interacting 
factor-like phosphatase) superfamily domain. BLAST searches using the predicted 
gene as query sequence returned a list of legumain sequences from species such as 























Figure 3.1.7 Bioinformatic analyses of Contig1466 from Blastocystis draft genome. 
A, three genes were predicted from the nucleotide sequence of Contig 1466 by the 
program GENSCAN. Genes 1 and 2 were complete and gene 3 was incomplete. B, in 
silico translated peptide sequence of the predicted gene 2. Sequenced peptides of 
MAb 1D5 target protein were marked in red. C, conserved domain analysis of gene 2 
showing a complete peptidase C13 domain and incomplete NIF (NLI interacting 






3.2 MAb 1D5 targets a novel cysteine protease legumain at cell surface to trigger 
Blastocystis cell death 
3.2.1 Characterization of the cysteine protease legumain in Blastocystis 
A cDNA library was constructed for Blastocystis subtype 7 using CloneMinerTM 
cDNA Library Construction Kit (Invitrogen). Primers were designed to amplify part 
of the predicted legumain gene, starting from the N-terminus of the predicted gene 
product till the last MS/MS sequenced peptide. The complete peptidase C13 
superfamily domain was included in this sequence. The PCR product had 990 bps 
(Figure 3.2.1) and encoded a protein of 330 amino acid residues (GenBank accession 
number: ACO24555) (Figure 3.2.2). All the seven MS/MS sequenced peptides could 
be matched on the peptide sequence of the PCR product (Figure 3.2.2). Theoretical 
molecular weight of this peptide sequence was 37.5 kD and pI value was 4.9 as 
calculated by the software Vector NTI. As with other legumains, the Blastocystis 
ortholog presumably codes for a precursor which is auto-cleaved at the C-terminal 
asparagine residue (Chen et al., 2000), possibly at N285 to result in the mature form 
(30 kD protein). Blastocystis legumain contains a catalytic dyad with the motif His-
Gly-spacer-Ala-Cys, which is also found in other legumains (Figure 3.2.3) and in 
caspases (Chen et al., 1998). Multiple sequence alignment using ClustalW showed 
that Blastocystis legumain had a highly conserved catalytic domain of 40% to 60% 
sequence similarity to legumains from other species, but possessed unique N and C-
terminus regions (Appendix II). Signal peptide prediction (http://rpsp.bioinfo.pl) 
showed that the first 15 amino acids (KFVSIALLRVLALAAA) comprised a putative 
secretary signal peptide. 
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1 KFVSIALLRV LALAAADNWA VLVAGSDGFW NYRHQADVAH AYQIMRRGGI
51 PADHIVTMMY NDVASSSFNP FPGELYNHPG DESPDVYKGV VVDYEGEDVT
101 PENFMKVLLG DESTGKKVLK TNENDNIFMF FSDHGGPNVL CFPNGDLSKD
151 DFQATLKKMH EQKKYKHFVL YIEACYSGSM GVGFPEDLGI SIVTAANDSE
201 SSWGWYCGEE AVVKGKDIGS CLGDEFSVFW MEDTDKGEQR TETLNEQWKR
251 IHDGVTKSHA SRYGDVSFES DLIGEYVGYP EEKFNYDHQS SVAWDSRDAK






6 7  
Figure 3.2.1 Peptide sequence of PCR-amplified Blastocystis legumain (Genbank 
ACO24555). The seven sequenced peptides of MAb 1D5 target protein were marked 





Figure 3.2.2 Multiple sequence alignment of the catalytic domain of the legumain 
family. The sequence segments containing known or putative catalytic residues in the 
legumain family were aligned by Vector NTI. Blocks of four predominantly 
hydrophobic residues (highlighted with a black background) are located 2 or 3 
residues preceding each of the catalytic residues (asterisk). Other residues in the 
catalytic domains are highly conserved in legumain family. Sequences compared and 
their accession numbers were mouse (NP_035305), rat (NP_071562), human 
(AAH03061), bovine (NP_776526), frog (NP_001005720), zebra fish (NP_999924), 
Schistosoma (CAB71158), rice (BAC41386), tobacco (CAE84598), Blastocystis 
(ACO24555), Haemonchus (CAJ45481) and Trichomonas (AAQ93040). 
 
Blastocystis legumain was overexpressed in E. coli with a glutathione S-transferase 
(GST) tag (Figure 3.2.3). The recombinant protein was purified and found to have the 
expected size of 65 kD. Western blot analysis using anti-human legumain IgG or 
MAb 1D5 confirmed that the purified recombinant protein was a bona fide target of 
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MAb 1D5. The variations in band intensities may be due to MAb 1D5 and anti-human 
legumain possessing different affinities for precursor and mature forms of legumain. 
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Figure 3.2.3 Expression, purification and verification of Blastocystis legumain. The 
Blastocystis legumain gene was inserted into pGEX-6p-1 and expressed in E. coli 
BL21(DE3) with induction of 0.5 mM IPTG at 16 °C (lanes 1-3). The expressed 
recombinant legumain was then purified by glutathione affinity column and purity 
assessed by SDS-PAGE (lane 4).  Purified legumain was subjected to Western 
blotting and probed with anti-GST to confirm the purification (lane 5). Western blots 
of purified legumain and Blastocystis cell lysate were performed and probed with 
anti-human legumain and MAb 1D5, showing distinct bands at 65 kD (legumain with 
GST tag) and 30 kD (legumain). (Picture courtesy of Dr. Wu Binhui, Department of 
Microbiology, National University of Singapore, used with permission) 
 
The purified recombinant legumain was incubated at 30 °C with the legumain specific 
substrate Z-Ala-Ala-Asn-NHMec to test its activity. Buffers with pH range from 3 to 
8.8 were used (Figure 3.2.4). It was found that enzymatic activity of legumain peaked 
at two pH values, i.e. pH 4 and pH 7.4, the latter being the most optimal pH. Activity 
of Blastocystis legumain had a steep increase between pH 3 to 4 and a steep decrease 
from pH 4 to 5. From pH 5 to pH 7.4, the activity of legumain increased gradually. At 
pH higher than 7.4, the activity decreased sharply, which may result from lower 
stability of the active legumain. The reason for the unusual biphasic activity profile is 
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not known but may be related to the localization of Blastocystis legumain in 


























Figure 3.2.4 pH dependence of Blastocystis legumain. Purified recombinant legumain 
(r-legumain) and fluorogenic substrate (Z-Ala-Ala-Asn-NHMec) were incubated at 
30 °C with pH buffers in the range from 3 to 8.8. Legumain activity (fluorescence 
arbitrary units) was plotted against pH values. Data shown were means ± stand 
deviations (error bar) from three independent experiments. (Picture courtesy of Dr. 
Wu Binhui, Department of Microbiology, National University of Singapore, used 
with permission) 
 
3.2.2 MAb 1D5 targets legumain on the cell surface of Blastocystis 
In order to investigate the subcellular localization of legumain in Blastocystis cells, 
immunofluorescence studies of non-permeabilized cells were carried out using MAb 
1D5 or anti-human legumain as primary antibody and a secondary antibody 
conjugated to AlexaFluor 594 (red). DAPI (blue, staining nuclei) and FDA (green, 
staining cytoplasm and central vacuole) were also included as co-stains. It was 
observed that MAb 1D5 had the same staining pattern as anti-human legumain 
(Figure 3.2.5 and Figure 3.2.6). In healthy cells which were round and had strong 
stain of FDA (Breeuwer et al., 1995), only the cell surface was stained, showing a red 
color ring around the cell (arrow pointed). In contrast, red stains could be observed in 
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the cytoplasm, central vacuole and on the cell surface (triangle indicated) of those 
cells with irregular cell shape and faint FDA staining, which might have become 
unhealthy during the staining procedure and the antibody could penetrate into 
cytoplasm due to the loss of cell membrane integrity. In fact, the same staining pattern 
was observed in permeabilized cells as with unhealthy cells. These results suggest that 
Blastocystis legumain localizes on the cell surface as well as in cytoplasm and central 





Figure 3.2.5 Cell surface localization of MAb 1D5. Blastocystis cells were incubated 
with MAb 1D5 followed by incubation with AlexaFluor 594-conjugated secondary 
antibody (red). Nuclei were stained with DAPI (blue). Cytoplasm and central vacuole 
were stained with FDA (green). A, control experiment was performed with a non-
specific primary antibody. B, cells were not permeabilized prior to the addition of 
antibodies; arrow pointed were representative healthy cells showing cell surface 
staining while triangle indicated representative unhealthy cells showing staining of 
cell surface, cytoplasm as well as central vacuole. C, cells were permeabilized before 
antibody incubation.  
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Figure 3.2.6 Cell surface localization of anti-legumain. Blastocystis cells were 
incubated with antibody against human legumain followed by incubation with 
AlexaFluor 594-conjugated secondary antibody (red). Nuclei were stained with DAPI 
(blue). Cytoplasm and central vacuole were stained with FDA (green). A, control 
experiment was performed without primary antibody. B, cells were not permeabilized 
prior to the addition of antibodies; arrow pointed were representative healthy cells 
showing cell surface staining while triangle indicated representative unhealthy cells 
showing staining of cell surface, cytoplasm as well as central vacuole. C, cells were 
permeabilized before antibody incubation.  
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3.2.3 Inhibition of legumain activity by MAb 1D5 and other protease inhibitors 
triggered apoptosis in Blastocystis 
The protease activity of recombinant legumain was assessed using its fluorogenic 
substrate Z-Ala-Ala-Asn-NHMec in the presence of MAb 1D5, a non-specific IgM 
antibody, or different protease inhibitors (Figure 3.2.7). It was found that the 
legumain specific inhibitor Cbz-Ala-Ala-AAsn-RR-COOOEt (APE-RR) inhibited 
more than 90% of the legumain protease activity compared to MOCK control. Two 
other reported legumain inhibitors cystatin and Ac-YVAD-cmk (also known as the 
caspase-1 inhibitor) had about 45% and 15% inhibitory effect on the activity of 
recombinant legumain respectively. The cathepsin B inhibitor z-FA-fmk could not 
inhibit legumain activity even when the final concentration was increased to 5 folds. 
Interestingly, MAb 1D5 could also inhibit about 35% of legumain activity, whereas a 



































































Figure 3.2.7 Regulation of legumain protease activity by antibody and inhibitors. 
Purified r-legumain and fluorogenic substrate were incubated at 30 °C in presence or 
absence of antibody or protease inhibitor in PBS. MOCK control was performed with 
same volume of solvent solution of antibody or inhibitors. Values are means ± 
standard deviations (error bar) from three independent sets of experiment. *, p <0.01 
versus MOCK control. (Picture courtesy of Dr. Wu Binhui, Department of 
Microbiology, National University of Singapore, used with permission) 
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Since the cellular target of MAb 1D5 was found to be legumain and MAb 1D5 could 
inhibit legumain activity, it was hypothesized that inhibition of the surface legumain 
activity would trigger cell death in Blastocystis. To test this hypothesis, Blastocystis 
cells were incubated with MAb 1D5, non-specific IgM or various protease inhibitors 
for 4 h and assayed with Annexin V-FITC and PI staining to detect flipping of 
phosphatidylserine (PS) to the outer layer of cell membrane, an early marker of 
apoptosis. The flow cytometry scatterplots (Figure 3.2.8) showed that as compared to 
a baseline of less than 10% Annexin V-postive cells in MOCK control and non-
specific IgM control, the treatment with MAb 1D5, cystatin and the legumain 
inhibitor APE-RR increased the percentage of Annexin V-positive cells to 18.29%, 
49.53% and 47.04% respectively. To ensure reaction specificity, competitive 
inhibition assays were included. This involved the pre-incubation of MAb 1D5 or 
legumain inhibitor APE-RR with purified recombinant legumain protein (r-legumain) 
at a molecular ratio of 1:2 for 30 min before adding to cells. It was found that the 
extensive Annexin V-positive population seen in MAb 1D5 or legumain inhibitor 
treated cells was abrogated when MAb 1D5 or legumain inhibitor was pre-incubated 
with purified recombinant legumain protein (r-legumain). Caspase-1 inhibitor or 
cathepsin B inhibitor treatment did not alter the percentage of Annexin V positive 
cells. These results suggest that when legumain activity is inhibited, Blastocystis cells 
exhibited apoptotic features. 
 
To confirm the correlation between legumain protease activity and Blastocystis cell 
death, TUNEL assay was performed to assess DNA fragmentation, a marker of late 
apoptosis. Blastocystis cells were subjected to treatments with MAb 1D5 and various 
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protease inhibitors for 24 h and flow cytometric analysis was employed to quantify 
cells displaying DNA fragmentation (Figure 3.2.9). It was observed that MAb 1D5-
treated cells exhibited high TUNEL-positivity of 47.17%. Cystatin-treated cells 
showed 90.11% DNA fragementation, and cells exposed to the legumain inhibitor 
APE-RR had 80.25% DNA fragmentation. Percentages of TUNEL-positive cells for 
caspase-1 inhibitor treatment (2.5%) or cathespin B inhibitor (0.97%) treatment were 
close to that of MOCK control, similar to the observations with Annexin V assay. 
When MAb 1D5 was pre-incubated with r-legumain, the percentage of TUNEL 
positive cells decreased to 3.63%. Similarly, when legumain inhibitor APE-RR was 
pre-neutralized by r-legumain before adding to the cells, the percentage of TUNEL-
positive cell population dropped to 9.64%.  
 
The relation of legumain protease activity with cell death as indicated by Annexin V 
assay and TUNEL assay was summarized in Figure 3.2.10. It can be inferred that 
when legumain protease activity is blocked by MAb 1D5 or legumain inhibitors, 
Blastocystis cells were induced to undergo apoptotic PCD. 
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Figure 3.2.8 Annexin V apoptosis assay for inhibitor-pretreated cells. Cells were 
pretreated under different conditions (cultured with antibody, inhibitors, or 
neutralized antibody and inhibitor) for 4 h. Cells were stained with Annexin V-FITC 
to detect phosphatidylserine (PS) on cell surface and PI was used to stain cells with 
loss of plasma membrane integrity. 20000 cells were analyzed by a flow cytometer. 
The R5 quadrant represents the percentage of apoptotic cells (Annexin V-FITC 
positive/ PI negative cells) in the total cell population. MOCK control was performed 
with the same volume of antibody (PBS) or inhibitor (DMSO) diluent. Non-specific 
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Figure 3.2.9 TUNEL apoptosis assays for inhibitor-pretreated cells. Cells were 
pretreated under different conditions (cultured with antibody, inhibitors, or 
neutralized antibody and inhibitor) for 24 h. Fragmented DNA was detected with 
BrdUTP and labeled with AlexaFluor 488 conjugated anti-BrdU antibody. 20000 cells 
were analyzed by a flow cytometer. R3 represents the percentage of apoptotic cells in 
the total cell population. MOCK control was performed with the same volume of 
antibody (PBS) or inhibitor (DMSO) diluent. Non-specific IgM was used as negative 




Figure 3.2.10 Relationship between Blastocystis legumain protease activity and cell 
death. Data of purified r-legumain protease activity in presence or absence of 
antibody or protease inhibitor was retrieved from Figure 3.2.7 and combined with data 
on cell death percentages by Annexin V and TUNEL apoptosis assays retrieved from 
Figure 3.2.8 and Figure 3.2.9, respectively. Values were means ± stand deviations 
(error bar) from two independent sets of experiments. *, p <0.01 versus MOCK 








































































































































































































3.3 MAb 1D5 induces alternative cell death pathway through autophagy in 
Blastocystis 
 
3.3.1 Autophagy induced by MAb 1D5 in Blastocystis 
Previous studies demonstrated that apoptotic features induced by MAb 1D5 such as 
DNA fragmentation could be inhibited by the caspase inhibitor zVAD.fmk and 
mitochondrial outer membrane permeability (MOMP) inhibitor cyclosporine A; 
however, the cells could not be rescued from death (Nasirudeen and Tan, 2005). It 
was suggested that MAb 1D5 could elicit a PCD response in Blastocystis independent 
of caspases, mitochondria, or both, probably through an alternative pathway other 
than apoptosis (Nasirudeen and Tan, 2005; Tan and Nasirudeen, 2005). Since 
autophagic cell death has often been triggered as an alternative cell death pathway 
when apoptosis is blocked (Gozuacik and Kimchi, 2004), it is of interest to investigate 
whether MAb 1D5 can induce autophagic cell death in Blastocystis.  
 
In order to evaluate the possibility of autophagic cell death in Blastocystis treated with 
MAb 1D5, alone or in the presence of zVAD.fmk and/or cyclosporine A, cells were 
labeled with monodansylcadaverine (MDC), an autofluorescent, autophagolysosome 
marker that specifically labels autophagic vacuoles in in vivo and in vitro conditions 
(Biederbick et al., 1995; Munafo and Colombo, 2001; Niemann et al., 2001). While a 
certain level of background staining was seen in all cells, the true MDC positive 
staining could still be identified by the prominent and punctuate fluorescence patterns. 
The cells in each treatment were visually scored for MDC positive staining by 
fluorescence microscopy (Figure 3.3.1 A and 3.3.2). Cells treated with growth media 
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or a non-specific IgM monoclonal antibody, alone or in the presence of zVAD.fmk 
and/or cyclosporine A showed a small percentage of MDC-positive cells (<15%). In 
contrast, MAb 1D5-treated cells had a higher percentage (18.9%) of MDC-positive 
population compared with control. In the presence of pan-caspase inhibitor 
zVAD.fmk, 37.9% of MAb 1D5-treated cells showed MDC-positivity. However, 
when cells were exposed to MAb 1D5 in the presence of cyclosporine A, the 
percentage of MDC-positive cells decreased to 11.6%.  MAb 1D5-treated Blastocystis 
pre-exposed to zVAD.fmk and cyclosporine A showed 10.8% MDC-positive cells.  
 
To evaluate if the incorporation of MDC was indeed via autophagy, cells were pre-
treated with 3-methyladenine (3-MA), a specific inhibitor of autophagy. In the 
presence of 3-MA, an inhibitory effect on the incorporation of MDC was observed by 
fluorescence microscopy (Figure 3.3.1 B and 3.3.2). The percentage of MDC-positive 
cells observed in cells treated with MAb 1D5 alone or in the presence of zVAD.fmk, 
decreased to 11.4% and 14%, respectively. Hence, it is apparent that MDC 
incorporation was inhibited by 3-MA. These results indicated that the phenomenon of 
autophagy was triggered by MAb 1D5 treatment and was intensified in the presence 
of zVAD.fmk. In addition, the MAb 1D5-elicited autophagy might be associated with 





Figure 3.3.1 Exposure to MAb 1D5 increased MDC-positive staining in Blastocystis. 
A, fluorescent images of MDC staining of healthy and treated Blastocytis cells. B, 
MDC staining of healthy and MAb 1D5-treated Blastocystis cells in the presence of 3-
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MAb 1D5 + zVAD.fmk 
3-MA + MAb 1D5 + zVAD.fmk 
MAb 1D5 + CA MAb 1D5 + CA + zVAD.fmk 
N-S IgM + zVAD.fmk N-S IgM + CA 
3-MA + MAb 1D5 Healthy control with 3-MA 






Figure 3.3.2 Bar chart comparing MDC-positive Blastocystis cells under different 
conditions. 500 cells were counted in each treatment. Error bars = SD of two separate 
experiments. *, p<0.05. 
 
3.3.2 Occurrence of autophagy in Blastocystis colony 
Autophagy of Blastocystis has not been described in literature so far. However, one 
study reporting the ultrastructural observations of Blastocystis grown as colonies 
showed the presence of membrane-bound vesicles containing lysosome-like 
organelles, small particulate inclusions and mitochondria within the central region of 
colonies (Tan et al., 2001a), which implied the existence of autophagy in Blastocystis 
(Tan and Nasirudeen, 2005). 
 
To further characterize the autophagy phenomenon in Blastocystis colonies, MDC 







































































































be observed macroscopically in agar plate inoculated with Blastocystis cells on day 10. 
Using an inverted microscope, distinct biconvex disc-shaped colonies embedded in 
the soft agar were observed. Individual colonies were picked up by an inoculating 
loop and stained with MDC to examine the uptake of the stain by cells at the center 
and periphery of the colony (Figure 3.3.3). Cells located in the center of the colony 
showed a significant proportion of MDC-positive cells whereas cells located at the 
periphery of the colony had virtually no MDC positive staining. The data suggest that 




Figure 3.3.3 MDC staining of colony forms of Blastocystis. Blastocystis colonies 
embedded in the agar were removed by an inoculating loop and stained with MDC. 
Arrows point to representative MDC-positive cells. 
 
3.3.3 Autophagy induced by nutritional stress in Blastocystis 
Because it has been shown in other eukaryotic cells that autophagy is often rapidly 
up-regulated when cells are under nutritional stress (Levine and Klionsky, 2004b; 
Munafo and Colombo, 2001; Takeshige et al., 1992), Blastocystis was deprived of 
amino acids supply to further study and ascertain the autophagy phenomenon in 
Blastocystis. 
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Blastocystis cells were incubated in normal IMDM medium (control) or in HBSS for 
one to three hours. After the treatments, cells were stained with MDC and the MDC 
positive cells were scored. As shown in Figure 3.3.4, the percentage of MDC-positive 
cells increased from 6.7±0.9% in cells incubated in normal growth medium to 
19.7±2.2% after one hour amino acid starvation. There was also a time-dependent 
increase of MDC-positive cells as the starvation progressed to two hour (28.6±0.2%) 
and three hour (38.0±1.4%) periods. Hence, these results suggested that autophagy 
was rapidly triggered in Blastocystis cells in response to amino acid starvation. 
 
Target of rapamycin (TOR) is a conserved Ser/Thr kinase and is a central controller of 
cell growth. It is a negative regulator of autophagy and inhibition of TOR leads to 
induction of autophagy (Meijer and Codogno, 2004). Nutrient starvation or absence of 
growth factors can inhibit TOR and triggers autophagy in yeast and mammalian cells 
(Lum et al., 2005b; Wullschleger et al., 2006). It is very likely that the TOR signaling 
pathway also exists and functions in Blastocystis and the accumulation of MDC 
staining observed in serum-starved Blastocystis cells was due to the inactivation of 
TOR. To verify the existence of TOR signaling network in Blastocystis, it was 
investigated whether rapamycin, the prototypical inhibitor of TOR, could induce 
autophagy in Blastocystis. 
 
Blastocystis cells were treated with 100 nM, 500 nM or 1000 nM rapamycin for a 
period of three hours. MDC staining was visually scored using fluorescence 
microscopy (Figure 3.3.5). Similar to amino acid starvation, punctuate intensive 
staining by MDC could also be observed in rapamycin-treated cells. As compared to 
DMSO control (8.0±1.0%), cells which had been incubated with 1000 nM rapamycin 
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had a significantly higher percentage of MDC positive cells (45.5±12.4%). 
Rapamycin at the concentration of 100 nM or 500 nM did not induce significant 
change in MDC accumulation. These results indicated that rapamycin could induce 
autophagy in Blastocystis and thus the TOR signaling pathway was likely to be 
conserved in Blastocystis. Trypanosome TOR was reported to have an IC50 for 
rapamycin of 152 nM after 72 h treatment (Barquilla et al., 2008). The fact that 
Blastocystis was insensitive to rapamycin concentration below 1000 nM may be due 
to the brief incubation period of 3 h. 
 
To evaluate if the incorporation of MDC was indeed dependent on autophagy, cells 
were pre-treated with 3-MA or wortmannin, inhibitors of autophagic sequestration. 3-
MA and wortmannin are phosphatidylinositol 3-kinase (PI3K) inhibitors and inhibit 
both class I and class III PI3K. Class I PI3K generates products to inhibit autophagic 
sequestration while class III PI3K products stimulate autophagic sequestration 
downstream of class I enzymes, so the overall effect of 3-MA and wortmannin is to 
block autophagy (Blommaart et al., 1997; Petiot et al., 2000). The addition of 3-MA 
to 3 h amino acid-starved cells decreased the percentage of MDC positive cells from 
38.0±1.4% to 9.5±0.6% and the addition of wortmannin decreased the percentage to 
5.5±3.1% (Figure 3.3.4). Similar inhibitory effect was seen in rapamycin treatment as 
the MDC uptake of cells treated with 1000 nM rapamycin dropped from 45.5±12.4% 
to 8.14±0.6% and 8.7±1.6% upon addition of 3-MA and wortmannin respectively 
(Figure 3.3.5). Therefore, in the presence of 3-MA or wortmannin, there was an 
inhibitory effect on the incorporation of MDC in both amino acid-starved and 
rapamycin-treated Blastocystis cells. 
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Figure 3.3.4 MDC staining of Blastocystis cells deprived of amino acids for 1 h, 2 h 
or 3 h. A, representative fluorescence images of MDC staining; arrows pointed to 
cells stained positive for MDC. B, percentages of MDC positive cells. Data were 
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Figure 3.3.5 MDC staining of Blastocystis cells treated with 100 nM, 500 nM, or 
1000 nM rapamycin for 3 h. A, representative fluorescence images of MDC staining; 
arrows pointed cells stained positive for MDC. B, percentages of MDC positive cells. 
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It was observed that most of the MDC staining accumulated in the central vacuole. To 
elucidate the function of the Blastocystis central vacuole in autophagy, morphogical 
changes of amino acid-starved and rapamycin-treated cells was assessed via confocal 
microscopy after co-staining with MDC and Lysotracker. Lysotracker is a fluorophore 
which selectively accumulates in acidic compartments such as lysosomes whereas 
MDC was first described as a specific marker of autophagic vacuoles (Biederbick et 
al., 1995). By double staining, the dynamics of autophagy process was anticipated 
because early autophagosomes should only be stained with MDC and after their 
fusion with lysosomes co-localization could be observed. However, Figure 3.3.6 
showed that MDC staining and Lysotracker almost always co-localized. MDC or 
Lysotracker single-labeled controls were checked to ensure no cross-talk or bleed-
through of the two fluorescent dyes (results not shown). This was not surprising since 
the specificity of MDC staining was cautioned by other workers previously and MDC 
was suggested to be like other acidotropic dyes (e.g. Lysotracker) and may 
preferentially label later stages in the degradation process of autophagy. Early 
autophagosomes may not be readily labeled by MDC because they are not acidic 
(Bampton et al., 2005; Klionsky et al., 2008; Mizushima, 2004). Nonetheless, these 
results suggest that in Blastocystis MDC and Lysotracker labeled the same autophagic 
compartments of acidic pH although the detailed nature of the structure awaits further 
investigation. 
 
Examinations of the confocal microscopy images revealed unique MDC staining 
patterns in Blastocystis. Most of the extensive staining was seen inside the central 
vacuole as either individual circular specks or irregular shaped objects, which were 
likely to be clusters of several specks. The size of MDC-labeled individual specks was 
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0.5 - 1 µm, comparable to the autophagosomes in yeast (0.3 – 0.9 µm) (Yorimitsu and 
Klionsky, 2005). However, the size of the irregular shaped objects was 2 - 8 µm and 
has not be found in yeast or mammalian cells, except for the 5 – 10 µm 
autophagosomes containing bacteria or protozoan parasites (Andrade et al., 2006; 
Nakagawa et al., 2004). Interestingly, in another enteric protozoan parasite 
Entamoeba invadens, the sizes of autophagosome-like structure were very similar to 
the findings in Blastocystis (Picazarri et al., 2008). In their study, the size of Atg8-
associated structures varied from less than 1 µm to greater than 4 µm and the 























































Figure 3.3.6 A, B Confocal microscopy images of healthy Blastocystis cells stained 


















































Figure 3.3.6 C, D Confocal microscopy images of Blastocystis incubated under 























































Figure 3.3.6 E, F Confocal microscopy images of Blastocystis incubated under amino 
























































Figure 3.3.6 G, H Confocal microscopy images of Blastocystis incubated under 



























































Figure 3.3.6 I, J Confocal microscopy images of Blastocystis incubated with 







Amino acid-starved or rapamycin-treated Blastocystis cells displayed ultrastructural 
features resembling those of autophagy (Figure 3.3.7). As compared to untreated 
control (Figure 3.3.7 A, B), most of the treated cells showed cytoplasmic vacuoles 
with membranous inclusions and numerous vacuoles were observed to be 
accumulating within the central vacuole. The content of the autophagic-like vacuoles 
included intact mitochondria, membrane whirls, and amorphous materials. The 
presence of vacuoles containing membranous inclusions or intact organelles is highly 
suggestive of autophagy. The size of most autophagic vacuoles observed in TEM was 
0.5 – 1 µm, while some were 2 µm (Figure 3.3.7 I), 4 µm (Figure 3.3.8 A) and 6 µm 
(Figure 3.3.7 K arrow pointed) in size. This is consistent with the size of MDC-
labeled structures observed by confocal microscopy. Less frequently, it was observed 
that cytoplasmic contents were invaginating through vesicle- or thin tube-like 
membrane structures into the central vacuole (Figure 3.3.8). Interestingly, there were 
vesicles budding at the end of the filament-like structures. We hypothesize that the 
autophagic vacuoles were formed in different ways: membrane expansion and 
sequestration of cytoplasmic material in the cytoplasm (Figure 3.3.7 L); extensive 
vacuolation in cytoplasmic regions near to the central vacuole and formation of 
vesicles which invaginate into the central vacuole (Figure 3.3.8 A-D); formation of a 
thin tube-like structure which extrudes into the central vacuole and budding off 
vesicles at the end of the tubular invagination into the central vacuole (Figure 3.3.8 E-
G). All of the autophagic vacuoles end up in the central vacuole. It is likely that 
lysosomes are transferred from the cytoplasm into central vacuole in the meantime 






Figure 3.3.7 A-E Ultrastructural observations of autophagic vacuoles deposited in the 
central vacuole of Blastocystis. A-B, untreated controls displayed normal cell 
morphology. The central vacuole has flocculent contents. Nu, nucleus; M, 
mitochondrion; G, Golgi apparatus; L, lipid inclusion; CV, central vacuole. C, an 
amino acid-starved cell showing numerous autophagic-like vacuoles within the 
central vacuole. D is enlarged from boxed region in C, showing a mitochondrion 
appearing to be in the process of fusion with a lysosome. E is enlarged from another 
boxed region in C, showing several double-membrane vesicles with more 
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Figure 3.3.7 F-I Ultrastructural observations of autophagic vacuoles deposited in the 
central vacuole of Blastocystis. F, a rapamycin-treated cell harboring numerous 
vesicles in the central vacuole. G, enlarged from boxed region in F, showing two 
vesicles with an inner limiting membrane (arrow) and another vesicle containing 
enclosed membrane sacs and a lipid granule (dashed arrow). H and I (enlarged from 
H), a double membrane vacuole within the central vacuole of a rapamycin-treated cell, 
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Figure 3.3.7 J-N Ultrastructural observations of autophagic vacuoles deposited in the 
central vacuole of Blastocystis. J, an amino acid-starved cell. K is enlarged from J, 
showing a vesicle containing two mitochondia and cytoplasm (arrow), a vacuole 
containing membranous whirls (dashed arrow), a vacuole containing membranous 
whirls (dashed arrow), and another double membrane vacuole (arrow head). L is 
enlarged from J, showing a double membrane formed in the cytoplasm (arrow) and a 













Figure 3.3.8 A-D Ultrastructural observations of cytoplasmic invagination into the 
central vacuole when cells were deprived of amino acids or treated with rapamycin. 
A-D, invagination of membrane bound vesicles into the central vacuole. Multiple 
vacuolations were seen in the cytoplasmic region near the central vacuole and some 











Figure 3.3.8 E-G Ultrastructural observations of cytoplasmic invagination into the 
central vacuole when cells were deprived of amino acids or treated with rapamycin. 
E-G, invagination of membrane bound filaments into central vacuole with vesicles 








Previous studies showed that Blastocystis exhibited typical features of apoptosis when 
exposed to the surface reactive MAb 1D5 (Nasirudeen et al., 2001a; Nasirudeen et al., 
2001b; Tan and Nasirudeen, 2005). However, the mechanism is still unknown. It was 
shown that MAb 1D5 targeted specifically at a 30 kD protein on the plasma 
membrane (Tan et al., 2001b; Tan et al., 1996a; Tan et al., 1997). The MAb 1D5 
reactive protein is functionally important and identifying this protein will be a key 
initial step to delineate cell death pathways in Blastocystis. 
 
Two-dimensional gel based proteomics is very useful in resolving individual proteins 
in complex protein mixtures followed by identifying the protein of interest through 
mass spectrometry. The present study aimed to establish a 2-D proteome map of 
Blastocystis and to detect and identify the MAb 1D5 targeted protein from the 2-D 
proteome map. Sample preparation is a crucial step in 2-D electrophoresis but there is 
no single method that can be applied universally for all kinds of samples (Gorg et al., 
2004). The sample preparation procedures have to be determined empirically while 
conform to the rules of being as simple as possible and minimizing any protein 
modifications. Direct extraction with sample solubilization buffer after cell disruption 
is easy to manipulate and also minimize protein loss or modifications from additional 
sample preparation steps. However, when applied on Blastocystis, this method failed 
to generate good separation of proteins on 2-D gel. This may be due to the presence of 
interfering compounds in the sample such as salts, nucleic acids, lipids and 
polysaccharides. Blastocystis was reported to store many lipid granules in the central 
vacuole as well as cytoplasm (Yoshikawa et al., 1995b). One study showed that 
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Blastocystis isolates had 1.19 mg to 4.3 mg total lipid per 108 cells (Keenan et al., 
1992) while only 1 to 2 mg protein can be isolated from 108 cells (unpublished 
observation). Lipids may interact with membrane proteins and consume detergent 
(Gorg et al., 2004). Blastocystis also has a lot of carbohydrates at various cellular 
locations (Yoshikawa et al., 1995a) and carbohydrates may interact with carrier 
ampholytes and proteins (Gorg et al., 2004). Carbohydrates and other unknown 
components in the slimy surface coat of Blastocystis increase the viscosity of the 
sample and can obstruct gel pores. It is thus desirable to remove these interfering 
compounds. Precipitation is a common method to separate proteins from 
contaminants in the sample and to concentrate proteins. After evaluation of four 
precipitation methods, it was found that the coupling of TCA with acetone yielded 
most satisfactory result in terms of protein resolution and spot intensity. As protein 
loss (less than 30%) in the precipitation and resolubilization processes is at an 
acceptable range, TCA/acetone method should be an efficient method for 2-D analysis 
of Blastocystis proteins. However, it should be noted that a different set of proteins 
may be obtained using the precipitation method compared to extracting with sample 
solubilization buffer directly (Weiss and Gorg, 2008). 
 
Based on the optimized sample preparation method, the proteome map was 
constructed for Blastocystis and over 1000 protein spots were well resolved on the pH 
4-7 gel and around 900 spots were detected on the pH 3-10 gel. The narrow range of 
pH 4-7 yielded higher number of protein spots due to the better resolution of proteins 
in this range where most of proteins have their isoelectric points. The full resolving 
potential of 2-D gel analysis can be even greater using a combination of several 
micro-range IPG strips with single pH unit such as pH 3.9–5.1, 4.7–5.9, and 5.5–6.7. 
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In the present study, Blastocystis proteins in the alkaline range also showed good 
isoelectric focusing and were well separated. This is in line with the fact that 
TCA/acetone precipitation is good for enrichment and visualization of alkaline 
proteins (Gorg et al., 2004). Future studies can use the current sample preparation 
method with narrow range gel of pH 7-10 if the proteins of interest are basic proteins. 
It is currently not clear how many proteins are expected in the Blastocystis proteome. 
A recently released Blastocystis EST database contains 3330 EST clusters (O'Brien et 
al., 2007). Because EST databases are likely to exclude many lowly or transiently 
expressed genes, the number of genes should be higher. Five protein species are 
estimated for each gene in human cells due to alternative splicing and 
posttranslational modifications (Jungblut et al., 1996). In other protozoans such as 
Toxoplasma gondii, one gene also encodes more than one protein. Therefore, the 
number of proteins in Blastocystis is definitely higher than the number of EST 
clusters. Despite the considerable resolution power of the 2-D analyses, it is important 
to note that the protein gels in this study represent only a fraction of all Blastocystis 
proteins and there are some inherent technical limitations with 2-D gel electrophoresis. 
Membrane proteins are usually underrepresented in 2-D gels due to their low 
solubility and are still a challenge in proteomic studies (Rabilloud, 2009). Proteins of 
low abundance are also difficult to detect and prefractionation of cell extract such as 
separating by cell organelles can enrich these proteins.  
 
MALDI-TOF mass spectrometry is a rapid and efficient method for protein 
identification. The protein of interest is digested by an enzyme such as trypsin, and 
then analyzed by MALDI-TOF mass spectrometry. The generated peptide mass 
fingerprint data are compared with theoretical fingerprint profiles derived from in 
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silico digestion of a database of known proteins (Henzel et al., 1993). However, there 
is no available protein database for Blastocystis. Searching NCBI nonredundant and 
Swissprot protein database using the peptide mass fingerprinting data of selected 
Blastocystis protein spots from 2-D gel failed to generate any significant matches. The 
feasibility of scanning the peptide mass fingerprint against the theoretical translation 
and proteolytic digest of an unpublished in-house draft genome was then investigated. 
The draft genome was not annotated yet and consisted of contigs of varied lengths. 
The contigs were in silico translated in all six frames for MASCOT searching. For the 
16 selected landmark proteins analyzed, it was demonstrated that statistically 
significant match to a certain genome contig could be produced by this method (Table 
3.1.1). The matched genome contig sequence was also found to cover the major peaks 
of the mass spectra. Subsequent bioinformatic analyses such as similarity search by 
BLAST and conserved domain prediction helped to preliminarily annotate the 
identified protein. Therefore, until any annotated genome database becomes available, 
this strategy can be used to identify Blastocystis proteins in future proteomic study 
and to facilitate downstream functional analysis. Very recently, a Blastocystis EST 
sequence database with automatic annotation was published (O'Brien et al., 2007). 
BLAST analysis of the 16 proteins identified through use of the draft genome 
translated database showed corresponding matches in the EST database, which also 
confirmed the robustness of the genome approach.  
 
This study aimed to identify the MAb 1D5 targeted protein. Using 2-D gel followed 
by immunolabeling with the MAb, the immunoreactive spots were precisely located. 
In-gel digestion of the targeted spots followed by MALDI-TOF MS analysis enabled 
the identification of genomic origin of the protein recognized by the MAb. After 
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MALDI-TOF MS, the protein of interest was further subjected to tandem MS analysis. 
In tandem MS, selected peptide ions are introduced to a collision chamber and a 
collision gas will cause stepwise fragmentation along the peptide backbone. The 
series of fragments differ in mass by a single amino acid and the amino acid sequence 
of the peptide can be deduced (Kuster et al., 2001). Tandem MS is believed to provide 
authoritative identifications of the partical amino acid sequences and combining the 
peptides mass fingerprint with the partial amino acid sequences obtained from 
MS/MS produces high confidence identification of proteins (Barrett et al., 2005). The 
application of tandem MS in the MAb 1D5 reactive protein spot was successful as 
seven tryptic peptides were sequenced in total. This facilitated the unambiguous 
identification of the genomic origin of the MAb 1D5 reactive protein. The current 
approach to identify the target of MAb is based on 2-D gel immunoblotting. An 
alternative and often used approach is through immunoprecipitation. However, the 
isotype of MAb 1D5 is IgM and the pentameric structure of IgM makes it difficult to 
use in immunoprecipitation. IgM antibodies also do not bind well to protein A or 
protein G. Therefore, this study demonstrates that 2-D gel immunoblotting is an 
effective method for identifying the target of IgM antibodies. 
 
Most of sequenced peptides were localized on a putative gene predicted by the 
program GENSCAN. Bioinformatic analysis of the translated protein sequence 
showed that the putative gene encoded a protein containing a complete peptidase C13 
domain and an incomplete NIF (NLI interacting factor-like phosphatase) superfamily 
domain. All of the sequenced peptides were within the peptidase C13 domain, and 
none fell within the NIF superfamily domain at C-terminus. Out of the four exons 
predicted in the putative gene by GENSCAN, the score for the predicted exon 
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containing the peptidase C13 domain was very high, whereas score for other exons 
were very low. Therefore, the real gene should definitely contain the regions covering 
the C13 domain, while other predicted exons may not be included. A 5' and 3' RACE 
(Rapid amplification of cDNA end) PCR will define the start and end of the coding 
sequence.  
 
The peptidase C13 domain characterizes a family of asparaginyl endopeptidases, also 
known as legumains (Chen et al., 1997). Legumain (EC3.4.22.34) is a novel class of 
cysteine protease and was originally identified from the plant legume, hence the name 
legumain (Abe et al., 1993; Ishii, 1994). It was first identified in animals in the blood 
fluke parasite Schistosoma mansoni (Dalton et al., 1995), and has since been found in 
mammals, helminth worms and the protozoan Trichomonas vaginalis  (Beck et al., 
2001; Chen et al., 2001; Maehr et al., 2005; Manoury et al., 1998; Shirahama-Noda et 
al., 2003). Legumains have specificity for the hydrolysis of bonds on the carboxyl 
side of asparagines (Li et al., 2003) and legumains from different species have been 
shown to function in the processing of other proteins, such as processing food storage 
proteins in plants(Muntz and Shutov, 2002), processing bacterial and endogenous 
peptides for MHC class II presentation in mammals (Manoury et al., 1998), and 
processing and activating cathepsin B zymogens in S. mansoni (Sajid et al., 2003).  
 
The present study is the first to describe the presence of a legumain in Blastocystis, a 
second protozoan legumain besides T. vaginalis legumain. Comparison of 
Blastocystis legumain protein sequence with other legumain sequences showed that 
Blastocystis legumain was 30.1% identical to human, 28.4% identical to blood fluke, 
and 22.8% identical to T. vaginalis legumains. Key conserved features include the 
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catalytic His-Cys dyad, 4 predominantly hydrophobic amino acids closely preceding 
each of the catalytic residues, putative N-terminal prodomain and C-terminal 
extension, activity against legumain substrates and inhibition by legumain-specific 
inhibitors. From the multiple sequence alignment, Blastocystis legumain possesses 
unique N and C terminal regions, suggesting downstream substrates, localization and 
other properties distinct from reported legumains.  
 
Regarding pH dependence of stability and activity, mammalian and plant legumains 
have been found to be unstable at neutral pH (Rotari et al., 2001), and exhibit optimal 
activity at low pH,  with the pH optimum of human legumain at pH 4.0 (Li et al., 
2003), pig legumain at pH 5.8 (Rotari et al., 2001) and kidney bean legumain at pH 
5.4 (Rotari et al., 2001). Legumains from parasite origins, in contrast, have pH 
optimum near neutral pH, e.g., T. vaginalis legumain at pH 7.0 (Leon-Felix et al., 
2004) and the helminth Haemonchus contortus and Schistosoma mansoni legumains 
at pH 7.0 (Oliver et al., 2006) and 6.8 (Dalton et al., 1995) respectively. Blastocystis 
legumain is active over the wide range of pH 4 to 8 with the optimum pH at 7.4, 
similar to what has been reported in T. vaginalis (Leon-Felix et al., 2004). It has been 
shown that parasitic cysteine proteases have a broad pH profile and serve various 
extra-lysosomal functions as opposed to the narrow pH range of mammalian 
lysosomal cysteine proteases which primarily exert their activity in the lysosome 
(Sajid and McKerrow, 2002). Interestingly, Blastocystis legumain has biphasic pH 
dependence, with peaks at pH 4.0 and 7.4, a property that has not been seen in 
legumains from all other origins. It is presently unclear why Blastocystis legumain 
exhibits two peaks of enzyme activity. The localization of the enzyme on the cell 
surface and in intracellular compartments is consistent with activity peaks at neutral 
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and acidic pH values. It is postulated that Blastocystis legumain possesses multiple 
functions and plays important roles at the cell surface and within acidic compartments. 
Legumains are generally located within lysosomes of mammalian cells and vacuoles 
of plant cells but have been reported to localize to the cell surface of metastatic 
tumors (Liu et al., 2003) and on the microvillar surfaces of helminth intestinal cells 
(Oliver et al., 2006). Surface legumains were suggested to activate local zymogens 
which may aid tumor invasion or participate in helminth alimentary digestion of host 
proteins. Blastocystis cysteine proteases are able to cleave human immunoglobulin A 
(Puthia et al., 2005) and also induce pro-inflammatory responses in host cells (Puthia 
et al., 2008). The presence of legumain on the parasite surface may similarly function 
to activate these proteases. The localization of Blastocystis legumain to the cell 
surface is probably promoted by its uncommon secretory signal peptide. Such signal 
peptide has only been explicitly described in the legumain of the Chinese liver fluke 
Clonorchis sinensis (Ju et al., 2009), which was found in the excretory-secretory 
products as a serological antigen. 
 
Blastocystis legumain activity was abolished by legumain specific inhibitor APE-RR, 
an aza-Asn derivative that does not cross react with caspases, papain and cathepsin 
(Asgian et al., 2002). It is moderately inhibited by cystatin and MAb 1D5 and weakly 
inhibited by caspase-1 inhibitor Ac-YVAD-CMK. Cystatins are potent inhibitors of 
the papain-like cysteine peptidases in the unrelated family C1 but also inhibit 
legumain, due to a separate site on the cystatin molecule (Alvarez-Fernandez et al., 
1999), while plant and mammalian legumains have been shown to cleave caspase-1 
substrates (Hatsugai et al., 2004; Rotari et al., 2001). Hence, Blastocystis legumain 
shares a number of characteristics with legumains of other origins. 
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In plants, legumain is essential for hypersensitive response cell death (Hatsugai et al., 
2004) and is also involved in fungal toxin FB1-induced plant cell death (Kuroyanagi 
et al., 2005). Virus-induced gene silencing of VPE revealed loss of VPE and caspase-
1 cleavage activities concomitant with loss of PCD features upon TMV-induction, 
resulting in increased virus proliferation. Hence, VPE-mediated cell death is 
important for resistance to pathogen infection. VPE targets that mediate HR cell death 
are currently unknown (Lam, 2005). In contrast to the plant model, the present studies 
suggest that Blastocystis legumain mediates pro-survival functions. This is evidenced 
by the significant PS-externalization and in situ DNA fragmentation upon incubation 
with legumain inhibitors. There was a positive correlation between the extents of 
these PCD features with the degree of legumain inhibition (Figure 3.2.10), with 
legumain-specific inhibitor and cystatin inducing the greatest amount of PS flipping 
and DNA fragmentation. The data indicates that PCD in Blastocystis is regulated by 
surface legumain activity and suggests a pro-survival role for the surface molecule. 
However, although cystatin only caused 45% inhibition of Blastocystis legumain 
activity as compared to 90% inhibitory effect by legumain-specific inhibitor, the 
extent of cell death induced by cystatin was even higher than that induced by 
legumain specific inhibitor. Since cystatin is also a high affinity inhibitor of family C1 
cysteine proteases, it is possible that there is a papain-like cysteine protease 
downstream of legumain whose inhibition triggers PCD and by inhibiting both 
legumain and this hypothetical substrate protease cystatin causes massive cell death in 
Blastocystis. Because cystatin is a cell impermeable inhibitor (Claveau et al., 2000), it 
is thus unlikely that PCD induction was due to inhibition of some other intracellular 
enzyme. It is speculated that Blastocystis cell surface legumain may be responsible for 
processing and activating a downstream cysteine protease which also localizes at the 
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cell surface and has important function in nutrition uptake. Alternatively, cystatin may 
independently trigger PCD by inactivating papain-like proteases on the parasite 
surface. Previous studies showed that MAb 1D5 exposure induces PCD features 
rapidly, evidenced by PS-externalization and caspase-like activity by 2 h post 
induction (Nasirudeen et al., 2001a; Nasirudeen and Tan, 2004), suggesting a direct 
role for legumain in Blastocystis PCD. In this study, it was demonstrated that MAb 
1D5 was able to inhibit Blastocystis legumain. It is known that enzymes can be 
inhibited by some of their specific antibodies through mechanisms such as steric 
hindrance and conformational changes (Gelboin and Krausz, 2006). MAbs of 
different Ig subtypes have been used to study the role of individual cytochrome P450 
isoforms. Because of their high specificity and high inhibitory activity, carefully 
selected MAbs were suggested to be superior to chemical inhibitors to target specific 
cytochrome P450 enzymes (Gelboin and Krausz, 2006). MAb 1D5 is the first reported 
legumain-specific antibody which has an inhibitory effect on this enzyme. The 
mechanism by which Blastocystis legumain modulates PCD is presently unclear. 
Human embryonic kidney (HEK) 293 cells overexpressing legumain appear more 
resistant to apoptosis compared to cells that have basal levels, and is associated with 
tumor invasion and metastasis in vivo (Liu et al., 2003). More work needs to be done 
to unravel the pro-survival mechanism of Blastocystis legumain and to determine if it 
is similar to that of tumor cells. Identification of the substrates of legumain will take 
us one step further in delineating the legumain-mediated PCD pathway. 
 
It was reported that MAb 1D5-treated Blastocytis pre-exposed to zVAD.fmk and/or 
cyclosporine A was not rescued from cell death (Nasirudeen and Tan, 2004, 2005). In 
the presence of either inhibitor, there seemed to be a compensatory mechanism as the 
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cells were able to trigger the mitochondrial-dependent death pathway in the absence 
of caspase-like activity, and vice versa. However, even though both caspase-like 
activity and MOMP were inhibited and DNA fragmentation was abolished completely, 
the cells continued to die. Therefore, besides apoptosis, other cell death pathways 
might exist in Blastocystis and be triggered upon MAb 1D5 induction. 
 
Autophagy has been suggested to play a role in alternative cell death pathway (Berry 
and Baehrecke, 2008; Kourtis and Tavernarakis, 2009). In order to investigate if 
caspase-independent PCD in MAb 1D5-treated Blastocystis occurred through 
autophagy, a specific autophagic marker monodansylcadaverine (MDC) was used. 
Autophagy is often characterized by the presence of vacuoles containing sequestered 
cytoplasmic components and organelles and MDC can accumulate in these vacuoles 
due to ion trapping mechanism and interaction with membrane lipid, functioning as a 
solvent polarity probe (Niemann et al., 2000).   
 
MDC-labeled vesicles were observed in MAb 1D5-treated Blastocystis and 18.9% of 
cells showed MDC positive staining, suggesting that autophagy was triggered by 
MAb 1D5. The interplay between apoptosis and autophagy is complex and not fully 
understood yet. Similar stimuli can induce either apoptosis or autophagy 
concomitantly, sequentially, or in a mutually exclusive manner (Maiuri et al., 2007). 
It appeared that MAb 1D5 could trigger both apoptosis and autophagy, although 
apoptosis was still the major mode of cell death. However, when Blastocystis was pre-
exposed to zVAD.fmk before incubation with MAb 1D5, the percentage of MDC-
positive cells increased to 37.9%, indicating an up-regulation of autophagy when 
caspase-like activity was blocked. This is consistent with many metazoan cell lines 
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which were sensitized to autophagic cell death in the absence of caspase activation 
(Vandenabeele et al., 2006; Yu et al., 2004). The current study also demonstrated the 
importance of mitochondrial outer membrane permeabilization (MOMP) in 
MAb 1D5-initiated autophagy as when MOMP was inhibited by cyclosporine A, 
MDC positive staining was abolished in MAb 1D5 treated cells, even with pre-
treatment of zVAD.fmk.  Mitochondrial damage has been reported to be a signal for 
autophagy in mammalian cells. Overexpression of mitochondrial calpain 10 was 
found to cause mitochondrial swelling and increased autophagy, which was blocked 
by cyclosporine A (Arrington et al., 2006). It is likely that autophagy was triggered in 
Blastocystis via MAb 1D5-mediated mitochondrial dysfunction. 
 
This study is the first to report the occurrence of autophagy in Blastocystis through 
induction by a cytotoxic antibody. Further analysis of Blastocystis colony forms 
revealed that autophagy also occurs naturally in this organism. Strong and punctate 
MDC staining was observed in cells located in the center of a Blastocystis colony. 
Within a colony, cells in the center have less access to nutrients and hence, they are 
mostly like to undergo starvation as compared to cells at the periphery of the colony. 
Cells grown in liquid culture but deprived of amino acids also had a high percentage 
of MDC-positive staining. In addition, time-dependent increase of MDC staining was 
observed during the first three hours of amino acid starvation. These results suggest a 
strong correlation between MDC staining and the nutritional state of the cell. Since 
MDC was reported to stain autophagic vacuoles and autophagy is rapidly up-
regulated in response to nutrient-deficient conditions in other organisms (Takeshige et 
al., 1992; Yorimitsu and Klionsky, 2005), the intensive MDC staining should be a 
good reflection of the autophagic activity in Blastocystis and can be used in future 
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investigation of autophagy in Blastocystis. The results also demonstrated that 
autophagy occurs naturally when cells have limited access to nutrients or can be 
rapidly induced by removing nutrients from culture media. 
 
Cells induce autophagy in response to nutrient scarcity and generate recycled 
metabolic substrates to maintain energy homeostasis (Meijer and Codogno, 2004; 
Tsukada and Ohsumi, 1993). However, when nutrient supply via autophagy becomes 
ultimately depleted in prolonged starvation, massive autophagy may contribute to cell 
death (Eskelinen, 2005; Galluzzi et al., 2008). Blastocystis grown in liquid culture 
also responded to starvation by initiating autophagy when the cells were deprived of 
amino acids.  
 
Results of the current study suggest that the some of the autophagy machinery is 
conserved in Blastocystis. Target of rapamycin (TOR) is a conserved Ser/Thr kinase 
and a negative regulator of autophagy. Rapamycin induces autophagy through 
inhibition of TOR (Meijer and Codogno, 2004). It was found that in Blastocystis, 
treatment with rapamycin elicited similar response to that of amino acid starvation. 
Rapamycin treatment was effective in intensifying MDC-labeled vesicles; hence 
Blastocystis is likely to have a homolog of TOR and the TOR signaling pathway 
should also exist and function in Blastocystis. The phosphatidylinositol 3-kinase 
(PI3K) inhibitors 3-MA and wortmannin was shown to inhibit the incorporation of 
MDC effectively. Both class I and class III PI3K have been reported to regulate 
autophagy in yeast and mammalian cells. Class I PI3K generates products to inhibit 
autophagic sequestration while class III PI3K products stimulate autophagic 
sequestration downstream of class I enzymes, so the overall effect of 3-MA and 
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wortmannin is to block autophagy (Blommaart et al., 1997; Petiot et al., 2000). 
Inhibition of MDC incorporation by 3-MA and wortmannin suggested similar 
regulation pathway existed in Blastocystis and also confirmed the autophagic nature 
of MDC-labeled vesicles. The concentration of 3-MA used to effectively inhibit MDC 
incorporation in Blastocystis is comparable to that in mammalian cells and many other 
cells (Munafo and Colombo, 2001).  However, the concentration of wortmannin 
needed to inhibit MDC incorporation was higher in Blastocystis (in the micromolar 
range) than in mammalian cells (in the nanomolar range), but is comparable to plants 
(µM) (Takatsuka et al., 2004). The different sensitivity range of wortmannin in 
Blastocystis, plants and mammalian cells may be due to the difference in the structure 
of PI3K subunit which wortmannin binds to. It was reported that wortmannin binds to 
the catalytic subunit of PI3K, while 3-MA interacts with the regulatory subunit of 
PI3K (Walker et al., 2000). 
 
Morphological examinations by confocal microscopy and transmission electron 
microscopy (TEM) revealed several unique features of autophagy in Blastocystis. 
Most of the extensive MDC staining was observed inside the central vacuole, 
suggesting a role of this organelle in the autophagy process. MDC stained structures 
either appeared as individual circular vesicles of size 0.5 - 1 µm or big clusters of 
several specks of size 2 - 8 µm. Similar big sized structures in autophagy was only 
described in another intestinal protozoan parasite E. invadens and their appearance 
was found to coincide with the initiation of encystation process (Picazarri et al., 2008). 
Since starvation was known to induce encystation in protozoan parasites such as 
Giardia lamblia and E. invadens (Avron et al., 1986; Lujan et al., 1996), it is possible 
that starvation has triggered some Blastocystis cells to transit into granular or cyst 
 112
forms and autophagy may promote the morphological changes through massive 
clusters of autophagic vacuoles. TEM is the most reliable method for monitoring 
autophagy (Mizushima, 2004). Highly polymorphic autophagic vacuoles were 
observed in amino acid-starved and rapamycin-treatecd cells. Based on these 
randomly observed profiles, it is postulated that the process of autophagy in 
Blastocystis starts from cytoplasmic membrane expansion to enclose organelles and 
other materials, or transfer of cytoplasmic components through vesicle- or tubular 
invagination and subsequent budding of vesicles into the central vacuole. 
Morphologically, the first scenario resembles that of macroautophagy, while the latter 
scenario is similar to microautophagy in the yeast. Regardless of the origin, all of the 
autophagic vacuoles appeared to be deposited into the central vacuole. The central 
vacuole is the largest organelle in Blastocystis vacuolar forms and takes up 
approximately 90% of the cell’s volume. It is speculated to be an important organelle 
of this organism. However, the function of central vacuole is still largely unknown 
(Tan, 2008). Through amino acid starvation and rapamycin treatment, the current 
study has clearly demonstrated a role of the central vacuole in autophagy. Previous 
studies using biochemical staining for carbohydrates or lipids showed that some cells 
accumulated these two substances in the central vacuole while some cells did not 
show any positive reactions to the stainings (Yoshikawa et al., 1995a; Yoshikawa et 
al., 1995b). It is likely that the lipids and carbohydrates are actually released from 
degraded autophagic vacuoles as autophagy serves to maintain homeostasis in healthy 
cells. The current study could also shed light to numerous unexplained observations 
with the central vacuole in previous studies. Cytoplasmic inclusions within the central 
vacuole reported in previously (Dunn et al., 1989b; Pakandl, 1999), which may be 
due to baseline autophagy in the parasites. The cytoplasmic projections into the 
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central vacuole was shown to increase during unfavorable culture conditions such as 
in the presence of high concentrations of antibiotics (Boreham and Stenzel, 1993). It 
is possible that the cells up-regulated autophagy in face of environmental stress. 
 
In this study, autophagy was found to be involved in the response to nutritional stress 
and in cytotoxic antibody mediated cell death. Triggering autophagy in response to 
nutrient scarcity may represent an adaptive response by generating recycled metabolic 
substrates to maintain energy homeostasis (Meijer and Codogno, 2004; Tsukada and 
Ohsumi, 1993). However, when nutrient supply via autophagy becomes ultimately 
depleted in prolonged starvation, massive autophagy may contribute to cell death 
(Eskelinen, 2005; Galluzzi et al., 2008). Autophagy may also serve as an alternative 
pathway to die when cells are stressed, such as with exposure to the cytotoxic 
antibody MAb 1D5, and may become the main pathway of cell death when classical 
apoptosis is inhibited. The cellular target of MAb 1D5 has been identified to be a cell 
surface legumain, an asparagine endopeptidase which was suggested to participate in 
helminth alimentary digestion of host proteins (Oliver et al., 2006). It is postulated 
that inhibition of legumain activity by MAb 1D5 hinders the nutritional uptake of 
Blastocystis and thus elicits a starvation response in the parasite.  
 
Figure 3.4.1 shows a proposed model of MAb 1D5-mediated PCD based on the 
present study and previous reports. The data in this chapter suggest that MAb 1D5 
targets at cell surface legumain to induce cell death in Blastocystis. Inhibition of 
legumain activity was also found to trigger apoptotic cell death in this organism. 
Since MAb 1D5 can inhibit legumain activity to some extent, the cytotoxicity of this 
antibody might be due to the inhibition of legumain. Besides apoptosis, autophagy 
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was also induced by MAb 1D5 in Blastocystis, which augment in the presence of 
caspase inhibitor. Since legumain as been suggested in the nutrient uptake of 
helminths, it is possible that autophagy triggered through legumain inhibition by MAb 
1D5 is similar to the starvation response. When cells are starved or treated with 
rapamycin, the target of rapamycin (TOR) is inhibited and autophagy is triggered. 
Autophagy may initially help the cells to survive by recycling its cytoplasmic 
constituents while eventually when cells fail to cope with stress it serve as alternative 





Figure 3.4.1 Proposed model of MAb 1D5 induced cell death in Blastocystis. CA, 
cyclosporine A. TOR, target of rapamycin. The binding of MAb 1D5 to legumain on 
the surface of Blastocystis leads to caspase-like proteases activation and MOMP, 
resulting in mainly apoptotic cell death and autophagic cell death to a less extent. In 
the presence of zVAD.fmk, the phenotype of cell death shifts more to autophagy. In 
addition, the presence of both zVAD.fmk and CA may trigger other death pathways 
which may be necrosis. 
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Chapter 4  
Mechanisms of Staurosporine-Induced PCD in Blastocystis 
 
4.1 Staurosprine triggers apoptotic features in Blastocystis 
Staurosporine, a protein kinase inhibitor, has been shown to induce PCD in all 
mammalian cells studied so far (Weil et al., 1996; Zhang et al., 2004) and is a 
valuable tool in PCD studies. Staurosporine at a concentration of 1 µM induced in 
Blastocystis a rapid cell death process with apoptotic features. As shown in Figure 
4.1.1, flow cytometry analysis of staurosporine-treated cells showed reduction in cell 
size at 3 h.  Dot plot of control cells displayed two distinct populations of cells. The 
population on the right represented larger cells (healthy cells and some early apoptotic 
cells) while the population on the left were necrotic cells, cellular debris and late 
apoptotic cells. When treated with staurosporine, there was a shift of the population to 
the left, indicating cell shrinkage. The histogram of forward size scatter (Figure 4.1.1 
B) also showed that staurosporine-treated cells were smaller than controls. The 
decrease in cell volume is an important early event of apoptosis that distinguishes it 




Figure 4.1.1 Effect of staurosporine on Blastocystis cell size as analyzed by flow 
cytometry. Blastocystis cells were incubated in the absence (Untreated) or presence 
(STS) of staurosporine (1 µM) for 3 h. DMSO control is the vehicle control. A, dot 
plot of forward (size) versus side (granularity) light-scatter. B, histogram 
representation of cell size. 
 
Blastocystis cells exposed to staurosporine maintained membrane integrity while 
exhibited phosphatidylserine (PS) externalization, another two characteristics of 
apoptotic cells (Figure 4.1.2). Propidium iodide (PI), when used in the absence of cell 
permeant, can only enters cells with damaged plasma membrane and stains the 
nucleic acid. Exclusion of PI demonstrates the preservation of membrane integrity. 
Combined use of PI and Annexin V, which binds to PS exposed on the outer layer of 
plasma membrane during apoptosis, can differentiate apoptotic, necrotic and healthy 
cells. As shown by flow cytometry analysis in Figure 4.1.2, staurosporine-treated cells 
had a very low percentage of cells with PI-positive staining, similar to that of 
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untreated and vehicle control. In contrast, heat-induced necrotic cells showed a very 
high percentage (86.31%) of PI-positive cells. While maintaining membrane integrity, 
staurosporine-treated cells had 33.17% subpopulation with Annexin V-positive and 
PI-negative staining, much higher than that of untreated and DMSO control. The 




Figure 4.1.2 Preservation of membrane integrity and externalization of PS in cells 
treated with staurosporine. Blastocystis cells were incubated in the absence (Untreated) 
or presence (STS) of staurosporine (1 µM) for 3 h. DMSO control is the vehicle 
control. Necrosis was induced by heating the cells in an 80 ºC water bath for 15 min. 
A, representative dot plots of Annexin V-FITC and PI staining assay. B, fluorescent 
microscopy image of staurosporine-treated cells stained by Annexin V-FITC and PI. 
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DNA fragmentation is a hallmark of apoptosis and usually a late event in apoptosis 
(Collins et al., 1997). TUNEL assay relies on the specific binding of terminal 
deoxynucleotidyl transferase (TdT) to exposed 3’-OH end of DNA followed by the 
synthesis of a labeled deoxyuridine molecule. Hence formation of DNA strand breaks 
as a consequence of endonuclease activity can be detected by flow cytometry analysis 
and expressed as a percentage of TUNEL-positive cells. As shown in Fig. 3, cells 
treated with staurosporine for 12 h exhibited 56.09% TUNEL-positivity, whereas 
untreated cells or vehicle control had a very low percentage of TUNEL-positive cells. 
Therefore, these results demonstrate that as in mammalian cells, staurosporine is also 




Figure 4.1.3 Representative histograms showing in situ DNA fragmentation analysis 
(TUNEL) of Blastocystis cells by flow cytometry. Cells treated with staurosporine for 
12 h had a significant increase in fluorescence intensity compared to untreated control 
or vehicle control. 
 
Transmission electron micrographs of staurosporine-treated cells also exhibited 
apoptotic features. As compared to the healthy control, cells exposed to staurosporine 
showed massive cytoplasmic vacuolation (Figure 4.1.4 A, D) and margination and 
segregation of nuclear chromatin (Figure 4.1.4 C, F). Condensed cells with collapsed 





Figure 4.1.4 Transmission electron microscopy of Blastocystis cells exposed to 
staurosporine for 3 h or 12 h. A, Healthy Blastocystis cell with normal morphology 
and DNA chromatin seen as a crescentic mass. B, massive cytoplasmic vacuolation in 
a cell treated with staurosporine for 3 h. C and F, condensed and segregated 
chromatin in cells treated with staurosporine for 12 h. D, coalescing of large 
cytoplasmic vacuoles with central vacuole in cell treated with staurosporine for 12 h. 
E, cell displaying collapsed central vacuole, severe shrinkage and multiple vacuoles. 
N, nucleus; CV, central vacuole; M, mitochondria. Bars, 2 µm. 
 
4.2 Regulation of staurosporine-induced apoptosis by mitochondria and cysteine 
proteases 
Since staurosporine was found to be a strong and robust inducer of apoptotic cell 
death in Blastocystis, it was used to screen potential regulators of Blastocystis PCD. 
The mitochondrion and cysteine proteases are the key regulators of apoptosis in 
higher eukaryotes. Therefore, the mitochondrial transition pore blocker cyclosporine 
A and inhibitors of a range of cysteine proteases was used to pre-treat the cells before 
their exposure to staurosporine. Staurosporine-treated Blastocystis showed 55.3±3% 
cells with PS exposure at 3 h and 51.3±1.7% cells with in situ DNA fragmentation at 
 120
12 h (Figure 4.2.3). Cyclosporine A completely abolished staurosporine-induced PS 
exposure and DNA fragmentation (Figures 4.2.1 and 4.2.2). The general cysteine 
protease inhibitor IA in the concentration range of 10 µM to 100µM could inhibit the 
two apoptotic features in a dose-dependent manner. However, even with the highest 
concentration 100 µM, IA could only reduce the percentage of Annexin V-positive 
cells and TUNEL positive cells to 25.6±3.8% and 22.7±3.1% respectively, and was 
thus not as effective as cyclosporine A. The effects of more specific inhibitors of 
different families of cysteine proteases were also investigated. The caspase inhibitor 
z-VAD.fmk and cathepsin B and L inhibitors z-FF.fmk, z-FA-fmk, CA-074-Me could 
not inhibit staurosporine-induced changes in PS exposure and DNA fragmentation. 
Interestingly, two calpain inhibitors z-LLL.fmk and ALLN could promote 
staurosporine-induced apoptotic responses, evidenced by the increased PS exposure to 
65.3±2.6% (z-LLL.fmk) and 64.6±2.2% (ALLN), and increased DNA fragmentation 
to 64.0±2.9% (z-LLL.fmk) and 62.7±2.0% (ALLN). However, because it was 
reported that the calpain inhibitor ALLN may also inhibit the proteosome (McDonald 
et al., 2001), the effect of the proteosome inhibitor epoxomicin was also tested. No 
inhibition of staurosporine-induced apoptotic features could be observed with pre-
treatment of epoxomicin (Figures 4.2.1, 4.2.2 and 4.2.3), indicating that the apoptosis-





Figure 4.2.1 Annexin V assay of inhibitor-pretreated cells. Cells were pretreated with 
protease inhibitors or CsA for 30 min before incubation with staurosporine for 3 h. 
The R4 quadrant represents the percentage of apoptotic cells (Annexin V-FITC 
positive/ PI negative cells) in the total cell population. Control was performed with 





Figure 4.2.2 TUNEL assay of inhibitor-pretreated cells. Cells were pretreated with 
protease inhibitors or CsA for 30 min before incubation with staurosporine for 12 h. 
The gated population represents the percentage of apoptotic cells (TUNEL positive) 
in the total cell population. Control was performed with the same volume of inhibitor 
diluent (DMSO). 
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Since calpain inhibitors were found to be augmenting staurosporine-induced apoptotic 
responses, the activity of calpain was assessed to see if there are any correlation 
between calpain activity and the apoptotic responses. As shown in Figure 4.2.3, 
calpain is constitutively active in healthy cells. However, exposure to staurosporine 
potently increased calpain activity to double that of the control. As expected, the 
calpain inhibitor z-LLL.fmk and ALLN completely inhibited the enzymatic activity of 
this protease. Therefore, the data suggests that Blastocystis calpain becomes more 
active upon exposure of cells to staurosporine and exerts a protective effect to the 
staurosporine challenge. The general cysteine protease inhibitors IA could inhibit 
some extent of the staurosporine-induced apoptotic responses whereas E64D, a broad-
range inhibitor of cathepsins and calpains had no inhibitory effect. The different 
inhibitory profile of these two protease inhibitors on calpain activity might provide an 
explanation to their opposing effects on apoptotic responses. Figure 4.2.3 showed that 
E64D was a potent inhibitor of calpain while IA only inhibited calpain activity 
moderately. It is likely that the two inhibitors could exert a protective effect on the 
cells by inhibiting an unknown protease which is responsible for mediating the 
staurosporine-induced apoptosis; however, the cytoprotective effect of E64D was 
neutralized by its apoptosis-promoting effect through inhibition of calpain. 
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Figure 4.2.3 Relationship between Blastocystis calpain protease activity and 
staurosporine-induced apoptosis. Data of Annexin V and TUNEL assays were 
retrieved from Figure 4.2.1 and Figure 4.2.2. Calpain activity assay was done by 
incubating cell lysates with fluorogenic substrate Ac-LLY-AFC. Values were means 





In the present study, the PCD-inducing potential of staurosporine in Blastocystis was 
investigated and the staurosporine-induced apoptotic signaling pathway was analyzed. 
The results demonstrated that the protein kinase inhibitor staurosporine can induce an 
apoptotic cell death process with several cytoplasmic and nuclear features of 
mammalian apoptosis, including cell shrinkage, exposure of PS molecules, 
maintenance of plasma membrane integrity, extensive cytoplasmic vacuolation, 
nuclear condensation and DNA fragmentation.  
 
Apoptosis in mammalian cells is mediated primarily by the activation of a family of 
cysteine proteases called caspases which cleave substrates critical for cell survival 
(Taylor et al., 2008). Another major executionary pathway is through mitochondrial 
outer membrane permeabilization and subsequent release of cytochrome c and other 
pro-apoptotic molecules (Kroemer et al., 2007). Using the mitochondrial transition 
pore blocker cyclosporine A, we showed that mitchondria also play important roles in 
the execution of apoptosis induced by staurosporine because cyclosporine A could 
effectively abolish staurosporine-induced PS exposure and DNA fragmentation. In 
Hela cells, mitochondria were found to have a central role in staurosporine-induced 
apoptosis and inhibition of the mitochondrial permeability transition prevented 
apoptosis (Tafani et al., 2001) Mitochondrial dysfunction has also been frenquently 
observed among protozoan parasites which are induced to undergo apoptosis 
(Deponte, 2008).  The involvement of mitochondria in programmed cell death was 
suggested to be of very ancient evolutionary origin (Arnoult et al., 2002). However, 
the pro-apoptotic molecules released by mitochondria in Blastocystis may be very 
different from that of mammalian cells and other protozoan parasites, since this 
 126
organism has unusual mitochondria that has been reported to lack cytochromes 
(Lantsman et al., 2008). 
 
Despite the indispensable role of caspases in mammalian apoptosis, no orthologous 
sequences have been found in protozoan parasites. Nonetheless, a lot of studies 
showed caspase-like activity by the cleavage of synthetic peptide substrates during 
cell death of protozoa, including Blastocystis (Nasirudeen et al., 2001a). It was found 
that caspase-3-like activity was triggered with a cytotoxic antibody and inhibition of 
the caspase-like molecule by z-VAD.fmk could inhibit the apoptotic features to some 
extent (Nasirudeen and Tan, 2004, 2005). In contrast to the involvement of caspase-
like molecule in the previous studies, the present data suggest that staurosporine-
induced apoptosis is independent of caspase-like molecules, as pre-treatment with z-
VAD.fmk did not alter the PS exposure or DNA fragmentation induced by 
staurosporine.  However, the general cysteine protease inhibitor IA could reduce the 
apoptotic responses in a dose-dependent manner, suggesting the involvement of a 
cysteine protease in the execution of staurosporine-induced apoptosis. As cysteine 
cathepsins have been suggested to regulate cell death in mammalian cells (Turk and 
Stoka, 2007), the effect of inhibitors of cathepsins was examined. Three different 
inhibitors of cathepsins, namely z-FF.fmk (cathepsins B and L), z-FA.fmk (cathepsins 
B and L) and CA-074-Me (cathepsin B), were used to pre-treat Blastocystis cells 
before exposure to staurosporine; however, Annexin V and TUNEL assays revealed 
that the cathepsin inhibitors did not have any inhibitory effect on staurosporine-
induced apoptosis.  
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Interestingly, calpain inhibitors z-LLL.fmk and ALLN were shown to enhance 
staurosporine-induced apoptosis while these potently inhibited calpain protease 
activity. Calpains are non-lysosomal calcium-dependent cysteine proteases and have 
been implicated in cell death signaling (Broker et al., 2005). Calpain was reported to 
facilitate caspase-3 activation by initial cleavage of the pro-enzyme (Blomgren et al., 
2001). Cleavage of Bax to its proapoptotic Bax/p18 was found to be mediated by 
calpain and mediate cytochrome c release and execution of apoptosis (Gao and Dou, 
2000). On the other hand, anti-apoptotic roles of calpains have also been suggested. 
For example, proteolytic cleavage of p53 protected cells from apoptosis induced by 
DNA damage (Kubbutat and Vousden, 1997). Capn4-/- MEFs lacked calpain 
activities and were more susceptible to staurosporine- and TNFα-induced apoptosis. 
The anti-apoptotic function of calpain might be related to activation of the PI3-
kinase/Akt survival pathway (Tan et al., 2006). It seems that calpains also play a 
protective role in staurosporine-mediated apoptosis in Blastocystis. Identifying its 
substrates may help to further dissect signaling networks regulating cell death in 
Blastocystis. It is worth noticing that the pre-treatment with cyclosporin A blocked 
apoptotic features induced by staurosporine but calpain activity was still up-regulated. 
Previous studies showed that apoptotic features induced by a cytotoxic antibody in 
Blastocystis could be inhibited by the combined use of z-VAD.fmk and cyclosporine 
A, but the cells could not be rescued from death, suggesting the existence of 
alternative cell death pathways in this parasite (Nasirudeen and Tan, 2005). It is likely 
that despite rescue of staurosporine-induced apoptosis by pre-treatment with 
cyclosporine A, the cells still die through alternative cell death pathways and thus 




Figure 4.3.1 Proposed model of staurosporine-induced apoptosis in Blastocystis. 
 
A model on the mechanism of staurosporine-induced apoptosis was proposed based 
on the results in this chapter (Figure 4.3.1). In summary, the present study has shown 
that staurosporine can induce apoptotic features in Blastocystis, which is mediated by 
mitochondria and an as yet unidentified cysteine protease; furthermore, calpain 









1. This study, being the first proteomic study of Blastocystis, has established a reliable 
method for two-dimensional gel electrophoresis and constructed a reference proteome 
map for this organism. 
 
2. Through proteomic analysis, this study has identified the cellular target of the 
cytotoxic antibody MAb 1D5 as legumain, with a conserved asparagines-specific 
cysteine protease C13 family domain. This is the key initial step in elucidating the 
mechanism of MAb 1D5-induced programmed cell death in Blastocystis. The present 
study is the first to describe the presence of a legumain in Blastocystis, a second 
protozoan legumain besides T. vaginalis legumain. 
 
3. While legumains of other organisms are usually found in lysosomal/acidic 
compartments, this study has demonstrated a cell surface localization of legumain in 
addition to cytosolic localization. Thus MAb 1D5 can assess the legumain on the cell 
surface. 
 
4. Inhibition of legumain activity by a legumain specific inhibitor induced apoptosis-
like PCD in Blastocystis. MAb 1D5 was also found to inhibit legumain activity. 
Therefore, this study strongly suggests that legumain has a key role in the regulation 
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of Blastocystis PCD and legumain is the first PCD mediator characterized in this 
organism. 
 
5. By using the autophagic marker monodansylcadaverine (MDC) and autophagic 
inhibitors 3-methyladenine and wortmannin, this study has shown the existence of 
autophagy in Blastocystis colony culture, or through exposure to MAb 1D5, amino 
acid starvation and treatment with rapamycin. This is the first report of autophagy in 
Blastocystis.  
 
6. MAb 1D5-induced autophagy was found to up-regulate in the presence of caspase 
inhibitor and appeared to be mediated through mitochondrial outer membrane 
permeabilization. Hence this study demonstrated the interplay between apoptosis and 
autophagy in Blastocystis. 
 
7. This study has presented unique features of autophagy in Blastocystis. The 
autophagic compartments was found to have unusually large size and appeared to be 
deposited into the parasite central vacuole. The central vacuole was postulated to be a 
repository for autophagic vacuoles.  
 
8. This study showed that Blastocystis exhibited apoptotic features in response to a 
common apoptosis inducer staurosporine. The apoptosis appeared to be mediated by 
mitochondria and an as yet unidentified cysteine protease, but not caspases or 
cathepsins B and L.  Calpain was found to play a protective role. This study 
demonstrated that Blastocystis PCD has multiple regulators. 
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5.2 Future studies 
This study suggests that the seemingly simple protozoon possesses complex cell death 
machinery. Further studies are required for more insights into its cell death 
mechanism. Future studies can be conducted to identify the downstream substrates of 
legumain and further dissect the signaling network of MAb 1D5-induced PCD. A 
possible role of legumain in nutrient uptake and autophagy can also be investigated 
since MAb 1D5 was shown to induce autophagy and legumain in helminths was 
suggested to be involved in alimentary digestion of host proteins. It can be examined 
whether staurosporine can trigger autophagy, because mitochodria were found to 
mediate staurosporine-induced apoptosis as well as MAb 1D5-induced apoptosis and 
autophagy. Mitochondria may be an important switch between apoptosis and 
autophagy in Blastocystis. When a high quality and annotated genome database 
becomes available, bioinformatic analysis can be performed to search for the 
orthologs of proteins involved in apoptosis and autophagy.  Proteomic studies of 
differentially expressed proteins of healthy cells and cells undergoing PCD can also 
help to identify the potential regulators of PCD. Further research in the mechanism of 
protozoan PCD may facilitate the development of novel therapeutics targeting novel 
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Appendix I Bioinformatic analysis of Contig 1466 from Blastocystis draft genome 
 
 
GENSCANW output for sequence Contig1466 
 
 
GENSCAN 1.0 Date run:  6-Jun-109 Time: 08:15:49 
 
Sequence Contig1466 : 5798 bp : 44.77% C+G : Isochore 2 (43 - 51 C+G%) 
 





Gn.Ex Type S .Begin ...End .Len Fr Ph I/Ac Do/T CodRg P.... Tscr.. 
----- ---- - ------ ------ ---- -- -- ---- ---- ----- ----- ------ 
 
 1.01 Init +     87    218  132  2  0   81   61   126 0.269  14.36 
 1.02 Intr +    358    493  136  0  1  -18   14    64 0.040  -6.46 
 1.03 Term +   1265   2031  767  0  2   19   37  1468 0.146 133.38 
 1.04 PlyA +   2071   2076    6                              -3.64 
 
 2.05 PlyA -   2101   2096    6                               1.05 
 2.04 Term -   2397   2149  249  0  0  -27   42   136 0.529  -1.80 
 2.03 Intr -   2618   2430  189  2  0   18    3   273 0.620  16.58 
 2.02 Intr -   3249   3159   91  2  1   55   51   136 0.724  11.60 
 2.01 Init -   4563   3401 1163  0  2   31   46  1722 0.815 160.46 
 2.00 Prom -   4644   4605   40                              -8.86 
 
 3.00 Prom +   4859   4898   40                             -10.35 
 3.01 Init +   5123   5788  666  1  0   74    1   990 0.934  89.13 
 
 
Predicted peptide sequence(s): 
 



































































































Gn.Ex : gene number, exon number (for reference) 
Type  : Init = Initial exon (ATG to 5' splice site) 
        Intr = Internal exon (3' splice site to 5' splice site) 
        Term = Terminal exon (3' splice site to stop codon) 
        Sngl = Single-exon gene (ATG to stop) 
        Prom = Promoter (TATA box / initation site) 
        PlyA = poly-A signal (consensus: AATAAA) 
S     : DNA strand (+ = input strand; - = opposite strand) 
Begin : beginning of exon or signal (numbered on input strand) 
End   : end point of exon or signal (numbered on input strand) 
Len   : length of exon or signal (bp) 
Fr    : reading frame (a forward strand codon ending at x has frame x 
mod 3) 
Ph    : net phase of exon (exon length modulo 3) 
I/Ac  : initiation signal or 3' splice site score (tenth bit units) 
Do/T  : 5' splice site or termination signal score (tenth bit units) 
CodRg : coding region score (tenth bit units) 
P     : probability of exon (sum over all parses containing exon) 




The SCORE of a predicted feature (e.g., exon or splice site) is a 
log-odds measure of the quality of the feature based on local 
sequence properties. For example, a predicted 5' splice site with 
score > 100 is strong; 50-100 is moderate; 0-50 is weak; and below 0 
is poor (more than likely not a real donor site). 
 
The PROBABILITY of a predicted exon is the estimated probability 
under GENSCAN's model of genomic sequence structure that the exon is 
correct. 
This probability depends in general on global as well as local 
sequence properties, e.g., it depends on how well the exon fits with 
neighboring exons.  It has been shown that predicted exons with 






















Description PssmId Multi-dom E-value 
cl02159, Peptidase_C13, Peptidase C13 family 121134 N/A 5e-98 
Peptidase C13 family The best-scoring hit on this query sequence is by member pfam01650: 
CD Length: 258  Bit Score: 353.52  E-value: 5e-98 
                      10        20        30        40        50        60        70        80 
              ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....| 
25185      19 NWAVLVAGSDGFWNYRHQADVAHAYQIMRRGGIPADHIVTMMYNDVASSSFNPFPGELYNHPgdESPDVYKGVVVDYEGE 98 
pfam01650   1 LWAVLVAGSNGYYNYRHQADVCHAYQLLKKFGIKDENIIVMMYDDIANNPENPFPGKIFNKP--NGTDVYKGVPIDYTGN 78 
                      90       100       110       120       130       140       150       160 
              ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....| 
25185      99 DVTPENFMKVLLGDEST---GKKVLKTNENDNIFMFFSDHGGPNVLCFPNGD-LSKDDFQATLKKMHEQKKYKHFVLYIE 174
pfam01650  79 DVTPRNFLAVLLGDKSAlkgSGKVLKSGPNDNVFIYFTDHGAPGVLGFPELDyLYAKDLAEALKKMHARGKYKKLVFYVE 158
                     170       180       190       200       210       220       230       240 
              ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....| 
25185     175 ACYSGSMGVGFPEDLGISIVTAANDSESSWGWYCGEEAvvkgkdIGSCLGDEFSVFWMEDTDKGEQRTETLNEQWKRIHD 254
pfam01650 159 ACESGSMFEGLPKDINIYATTAANADESSWGTYCPDPE------DGTCLGDLFSVNWMEDSDDHDLSKETLEQQFELVKN 232
                     250       260 
              ....*....|....*....|....* 
25185     255 GVTKSHASRYGDVSFESDLIGEYVG 279 
pfam01650 233 RTTGSHVMQYGDKSIPQLPVSLFQG 257  
cl02680, NIF, NLI interacting factor-like phosphatase 141620 N/A 2e-31 
NLI interacting factor-like phosphatase The best-scoring hit on this query sequence is by member TIGR02251: 
CD Length: 162  Bit Score: 132.42  E-value: 2e-31 
                      10        20        30        40        50        60        70        80 
              ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....| 
25185     418 EFLEYCSRFCEIVVFTASKQEYADRMLDFLDPEKKFIKHRLFRESCTKIGKVYVKDLNRLGRDLRRTVIIDNSIVSFGYH 497 
TIGR02251  49 EFLERVSKWYELVIFTASLEEYADPVLDILDRGGKVISRRLYRESCVFTNGKYVKDLSLVGKDLSKVIIIDNSPYSYSLQ 128 
                      90 
              ....*....|....*... 
25185     498 LDNGIPICSWFDNWKDQE 515 
TIGR02251 129 PDNAIPIKSWFGDPNDTE 146 
Blast search parameters  
Options:  Database: CDD   Low complexity filter: yes   E-value threshold:  0.010   Max. hits:  100  
Data Source:  Live blast search RID = 2MSPFVE101R  
System:  Search creator: newblast   Software: blastp 2.2.20+   Service: rpsblast  
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Appendix II Multiple sequence alignment of legumain sequences from Blastocystis and other species 
                 1                                                                                       90 
        1    (1) -------------KFVSIALLR-------VLALAAADNWAVLVAGSDGFWNYRHQADVAHAYQIMRRGGIPADHIVTMMYNDVASSSFNP 
        2    (1) ------------------------------STPSNIAGWAG-GKENLSVIPYIFQADVCHAYQLLKDGGLKDENIIVFMYDDIANNRENP 
        3    (1) -MMLFSLFLISILHILLVKCQLDTNYEVSDETVSDNNKWAVLVAGSNGYPNYRHQADVCHAYHVLRSKGIKPEHIITMMYDDIAYNLMNP 
        4    (1) -------------------------MFLVFSALSVSKQWAVLMAGSRGYNNYRHQADIFHIYDIIKTRGFPKENIITLAYNDVVRHKDNP 
        5    (1) --MIWEFTVLLSLVLGTGAVPL-------EDPEDGGKHWVVIVAGSNGWYNYRHQADACHAYQIVHRNGIPDEQIIVMMYDDIANSEDNP 
        6    (1) --MVWKVAVFLSVALGIGAVPI-------DDPEDGGKHWVVIVAGSNGWYNYRHQADACHAYQIIHRNGIPDEQIVVMMYDDIAYSEDNP 
        7    (1) --MTWRVAVLLSLVLGAGAVPVGV-----DDPEDGGKHWVVIVAGSNGWYNYRHQADACHAYQIIHRNGIPDEQIIVMMYDDIANSEENP 
        8    (1) --MIWKVAVLLSLVLGAGAVHIGV-----DDPEDGGKHWVVIVAGSNGWYNYRHQADACHAYQIIHRNGIPDEQIIVMMYDDIANNEENP 
        9    (1) --MLLHLAALVSFVLGATSLPF-------SNSEDTGKHWVVLVAGSNGWYNYRHQADVCHAYQIVKRNGIPDEQIVVMMYDDIANNEENP 
       10    (1) --MSPKTVAVLGLALSLGLVVSGF----PAEQPENGKHWVVIVAGSNGWYNYRHQADVCHAYQIVHKNGIPDEQIVVMMYDDLAESPDNP 
       11    (1) MTLLFRIAPLAALVISVASLAIP-------EIEG--ELYALLVAGSDGWWNYRHQADVSHAYHTLINHGVKPDNIIVMMKDDIANHERNP 
                 91                                                                                     180 
        1   (71) FPGELYNHPGDESPDVYKG-VVVDYEGEDVTPENFMKVLLGDESTGK-----KVLKTNENDNIFMFFSDHGGPNVLCFPN---GDLSKDD 
        2   (60) RPGVIINNPH--GHDVYKG-VPKDYVLEDVNANNFYNVILGNKSAVVG-GSGKVVNSGPNDHIFIYYTDHGGPGVVSMPSG--EDVYAND 
        3   (90) FPGKLFNDYN--HKDWYEG-VVIDYRGKKVNSKTFLKVLKGDKSAGG-----KVLKSGKNDDVFIYFTDHGAPGLIAFPD---DELYAKQ 
        4   (66) YPGKIFATAD--HKNVYPGRENIDYTGQDANAENFFRVLLGDTHNGR------ALQSTAEDDVFVYYDDHGAPGLLCVPHNNGPEIYADN 
        5   (82) TPGIVINRPN--GSDVYQG-VLKDYTGEDVTPKNFLAVLRGDAEAVKGVGSGKVLKSGPRDHVFVYFTDHGATGILVFPN---EDLHVKD 
        6   (82) TPGIVINRPN--GTDVYQG-VPKDYTGEDVTPQNFLAVLRGDAEAVKGIGSGKVLKSGPQDHVFIYFTDHGSTGILVFPN---EDLHVKD 
        7   (84) TPGVVINRPN--GTDVYKG-VLKDYTGEDVTPENFLAVLRGDAEAVKGKGSGKVLKSGPRDHVFIYFTDHGATGILVFPN---DDLHVKD 
        8   (84) TPGVVINRPN--GTDVYKG-VPKDYTGEDVTPENFLAVLRGDEEAVKGKGSGKVLKSGPRDHVFVYFTDHGATGILVFPN---EDLHVKD 
        9   (82) TKGIIINRPN--GTDVYAG-VLKDYTGDDVTPKNFLAVLSGDAEAVKGKGSGKVIHSGPNDHVFVYFTDHGAPGLLAFPN---DDLHVME 
       10   (85) TKGVVINRPN--GSDVYKG-VLKDYIGDDVTPENFLAVLKGDAASVKG-GSGKVLKSGPNDHVFVYFTDHGAPGLLAFPN---DDLHVDD 
       11   (82) YKGKIFNDPS--LTDVYEG-VVIDYKDKSVTPSNFLAILQGNETAVKG-GNGRVIHSTVNDRIFVYFSDHGGVGTISFPY---ERLTAKQ 
                 181                                                                                    270 
        1  (152) FQATLKKMHEQKKYKHFVLYIEACYSGSMGV-GFPEDLGISIVTAANDSESSWGWYCGEEAVVK--------GKDIGSCLGDEFSVFWME 
        2  (144) LIDVLKKKHASGTYDRLVFYLEACESGSMFDGLLPEGLDIYVMTASEPNEDSWATYCGEGTPDDPCLVECPPPEFQGVCLGDLYSVAWME 
        3  (169) FMSTLKYLHSHKRYSKLVIYIEACESGSMFQRILPSNLSIYATTAASPTESSYGTFCDDPT--------------ITTCLADLYSYDWIV 
        4  (148) IASVISQMKKEKKFRNLFFVIEACYSGSVAL--NITEPNVFIITAASDQQPSYSAQWDSRLHTFR-----------SNEFTQNFLKYILE 
        5  (166) LNETIRYMYEHKMYQKMVFYIEACESGSMMN-HLPPDINVYATTAANPRESSYACYYDEQR---------------STFLGDWYSVNWME 
        6  (166) LNETIHYMYKHKMYRKMVFYIEACESGSMMN-HLPDNINVYATTAANPRESSYACYYDEKR---------------STYLGDWYSVNWME 
        7  (168) LNKTIRYMYEHKMYQKMVFYIEACESGSMMN-HLPDDINVYATTAANPKESSYACYYDEER---------------GTYLGDWYSVNWME 
        8  (168) LNKTIRYMYEHKMYQKMVFYIEACESGSMMN-HLPDDIDVYATTAANPNESSYACYYDEER---------------STYLGDWYSVNWME 
        9  (166) LNKTIQLMYEKKTYKKLVFYIEACESGSMMN-HLPNNINVYATTAANSHESSYACYYDEKR---------------DTYLGDLYSVSWME 
       10  (168) LMDTIKYMHSNNKYKKMVFYVEACESGSMMK-PLPVDINVYATTAANPDESSYACYYDEAR---------------DTYLGDWYSVNWME 
       11  (165) LNSVLLDMHRKDKFGHLVFYLETCESGSMFHNILKKNINVYAVTAANPDESSYATYCFEDPR--------------LPCLGDEFSVTWMD 
                 271                                                                                    360 
 165
        1  (233) DTDKGEQRTETLNEQWKRIHDGVTK--------SHASRYGDVSFESDLIGEYVG----------------YPEEKFNYDHQSSVAWDSRD 
        2  (234) DSDVTDRDADSVQGQHSRVANRTAANITYGGYGSHVTEYGDIVVSFDRLSTYMGEASTNHSHASVNAMSFSTSSKSVDQYSAELFYLFTK 
        3  (245) DSQTHHLTQRTLDQQYKEVKRETNL--------SHVQRYGDTRMGKLHVSEFQG-SR--DKSSTENDEPPMKPRHSIASRDIPLHTLHRQ 
        4  (225) HPDG-----RLIDSANAAAERTVHS---------HVLSFGDMKLAKLPLSTFLLNAEPEEVNNEDSGDSENSVENGASTHVAALEYLQRR 
        5  (240) DSDVEDLTKETLHKQYQLVKSHTNT--------SHVMQYGNKSISAMKLMQFQGLKH---QASSPISLPAVSRLDLTPSPEVPLSIMKRK 
        6  (240) DSDVEDLTKETLHKQYHLVKSHTNT--------SHVMQYGNKTISTMKVMQFQGMKR---KASSPVPLPPVTHLDLTPSPDVPLTIMKRK 
        7  (242) DSDVEDLTKETLHKQYHLVKSHTNT--------SHVMQYGNKSISTMKVMQFQGMKH---RASSPISLPPVTHLDLTPSPDVPLTILKRK 
        8  (242) DSDVEDLTKETLHKQYHLVKSHTNT--------SHVMQYGNKSISTMKVMQFQGMKH---RASSPISLPPVTHLDLTPSPDVPLTILKRK 
        9  (240) DSDLEDLTKETLHKQFVLVKQHTNT--------SHVMQYGNRTISQMKVNQFQGNGK---ITSPPLNLEPVKHMDLTPSPDVPLAILKRK 
       10  (242) DSDVEDLSKETLAKQFKIVKAKTNT--------SHVMQYGNKTLSHMKVMAFQGSSKGLDKAVEPVSLPVIAEHDLMSSPDVPLAILKRK 
       11  (241) DSDETDITLETLNEQFDHVRDLVEE--------SHVQRYGNATMSKFPVSWFHGSGK--VKKVPKVMNKNRRRSGKWPSRDVELMYLERM 
                 361                                                                                    450 
        1  (299) AKFL-FLLYKYQHTTGSEKAKWEKLYLEEMSLR--------------------------------------------------------- 
        2  (324) HQNAPEGSHEKFEAHARLKEAISQRTQVDNNVKHLGELLFGVEKGNEVLHSVLPAGQPLVDSWDCLKSYVKIFEAHCGRLTSYGKKHIRG 
        3  (324) IMMT-NNAEDKSFLMQILGLKLKRRDLIEDTMKLIVKVMNNE----EIPNTKATIDQTLDCTESVYEQFKSKCFTLQQAPEVGG--HFST 
        4  (301) LKET-TSKEEANAIKGQIEHEVQRRARSDKIFDGITRRIVSNG---LPVGTKFVNYIDYDCYRTAIEGFRTYCGEIDENELAKMN-IFTH 
        5  (319) LMST-NDLQESRRLVQKIDRHLEARNIIEKSVRKIVTLVSGSAAEVDRLLSQRAPLTEHACYQTAVSHFRSHCFNWHNPTYEYALRHLYV 
        6  (319) LMNT-NDLEESRQLTEEIQRHLDARHLIEKSVRKIVSLLAASEAEVEQLLSERAPLTGHSCYPEALLHFRTHCFNWHSPTYEYALRHLYV 
        7  (321) LLRT-NDVKESQNLIGQIQQFLDARHVIEKSVHKIVSLLAGFGETAERHLSERTMLTAHDCYQEAVTHFRTHCFNWHSVTYEHALRYLYV 
        8  (321) LLRT-NNMKESQVLVGQIQHLLDARHIIEKSVQKIVSLLAGFGETAQKHLSERAMLTAHDCHQEAVTHFRTHCFNWHSVTYEHALRYLYV 
        9  (319) LMAT-NDILQARDIVREIKTHQEAKLLIKESMRKIVNMVTESDELTEEILTDQVIINDMHCYRDAAEHFKRQCFNWHNPLYEYALRHLYA 
       10  (324) LQKT-NDVDAVVGYLNEIHAHLQVRELLGNTMRKIVEHVVQDKEEVQDYLDGRSDLTQYNCYKTAVRHYKKHCFNWHEQKFEYALRHLYA 
       11  (321) KHFG-LATAEADDRISEIHKERQR---IEAVFENLVDSLVKDQTERSRILEERGGVEDLDCHDDVVTSLDSVCPDISKHDYVLK--FMNV 
                 451                        480 
        1  (331) ------------------------------ Blastocystis (ACO24555) 
        2  (414) IANICNAGITSEQMASTSAQACSS------ tobacco (CAE84598) 
        3  (407) LYNYCADGYTAETINEAIIKICG------- Blood fluke (CAB71158) 
        4  (386) LCERTDKKTILEDIKKECPVIQWDQEELYF Trichomonas (AAQ93040) 
        5  (408) LVNLCENPYPIDRIKLSMNKVCHGYY---- bovine (NP_776526) 
        6  (408) LVNLCEKPYPLHRIKLSMDHVCLGHY---- human (AAH03061) 
        7  (410) LANLCEAPYPIDRIEMAMDKVCLSHY---- mouse (NP_035305) 
        8  (410) LANLCEKPYPIDRIKMAMDKVCLSHY---- rat (NP_071562) 
        9  (408) LVNLCESGYPIERIHKAMDKVCNSWN---- frog (NP_001005720) 
       10  (413) LVNLCEGGYQAHRITAAMDDVCYFRD---- zebra fish(NP_999924) 
       11  (405) LNNLCTKFNDSAKIIKAMRATCSRRRS--- Haemonchus (CAJ45481) 
 
 
 
Color code: 
Blue: conservative 
green: similar 
yellow: identical
